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ABSTRACT 
 
Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome 
(AIDS) is a global problem. Introduction of antiretroviral therapy (ART) came as a relief 
to people living with HIV and AIDS as it improved their quality of life. However, 
maintaining high adherence levels to antiretroviral treatment is still a challenge in some 
settings yet strict adherence to treatment instructions is critical for successful 
suppression of HIV.  
 
A qualitative, descriptive phenomenological research was conducted to explore factors 
that influence adherence to antiretroviral therapy at Beatrice Road Infectious Disease 
Hospital (BRIDH).   
 
Purposive homogenous sampling was done. Data was collected from twenty patients 
through in-depth interviews.  
 
Study findings identified five main themes that facilitate adherence and these entail 
knowledge on HIV and AIDS and ART, motivation to live, adherence support networks, 
good service delivery and factors related to medication. 
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CHAPTER 1 
 
ORIENTATION TO THE STUDY 
 
1.1 INTRODUCTION 
 
HIV (Human Immunodeficiency Virus) and AIDS (Acquired Immune Deficiency 
Syndrome) is a global problem and is one of the most destructive epidemics that the 
world has ever witnessed (Ayalu, Reda & Sibhatu 2011:1). In the absence of cure 
antiretroviral therapy (ART) is the only treatment for HIV. 
 
The introduction of antiretroviral therapy (ART) coupled with expanded coverage in 
patients accessing ART has improved the quality of life and survival since about half of 
the people with a CD4 count less than 350 per ml, the current threshold for initiating 
treatment would die within 2 years if they did not get ARV treatment (UNAIDS 
2012a:50). In response to the patients demand for treatment, Zimbabwe Government 
through the Ministry of health introduced the antiretroviral therapy (ART) programme in 
2004 and since then many ART sites have been expanded throughout the country to 
ensure easy access to antiretroviral treatment (UNAIDS 2012b:30). As access to ART 
increased, concerns have been raised on how to maintain optimal adherence to ART. 
To achieve effective treatment ART requires a high adherence rate of 95% and above, 
but the challenge now remains on how to sustain such high percentage of adherence 
over long term (Ayalu et al 2011:1). Sub-optimal adherence has been reported to cause 
drug resistance. 
 
Antiretroviral treatment is complex in the sense that it requires strict adherence to 
scheduled time and stick to dietary requirements. At the ART clinic, once a patient has 
been considered eligible for treatment, the patient is offered counselling on the 
treatment regimens and adherence, then commenced on ART. The patients are 
required to take the treatment as prescribed, attend monthly review where progress is 
monitored and is also provided with monthly supply of antiretroviral drugs. The patient is 
expected to adhere all the treatment instructions but sometimes it may not be possible 
therefore viral suppression may not be maintained (Ministry of Health and Child Welfare 
2009b:12).  
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This study therefore explored PLWHA personal experiences of taking ARVs and 
assessed various factors that are required to increase and maintain the adherence 
levels to ART.  
 
1.2 BACKGROUND INFORMATION ABOUT THE RESEARCH PROBLEM 
 
Globally 34 million people were reported to live with HIV and AIDs and 1.8 million 
people had died of AIDS related illnesses by end of 2009 (World Health Organization 
[WHO] 2010:1). In Sub-Saharan Africa, ART clinics were scaled up and the number of 
people who were on ART tremendously increased  from an estimate of almost 100  000 
people in 2003 to 3.9 million in 2009 in (Ayalu et al 2011:1). 
 
Zimbabwe is among the countries that are mostly affected by the HIV and AIDS 
epidemic (UNAIDS 2012b:32). In 2011 an estimate of 1,159,097 million adults and 
children were living with HIV and AIDS in Zimbabwe (UNAIDS 2012b:1, and an estimate 
of about 597 293 patients were in need of antiretroviral therapy (ART) as of December 
2011 (UNAIDS 2012b:1). In response tremendous strides were made in scaling up ART 
clinics such that by December 2011, 141 initiating sites and 449 follow up sites were 
fully functional in Zimbabwe (UNAIDS 2012b:31). The concern remains on ensuring that 
optimal adherence is maintained in this long life complicated treatment. Skovdal, 
Campbell, Nyamukapa and Gregson (2011b:1) also cited that ART being  a complex 
treatment, requires not only availability of the ART sites, but need to ensure that 
patients  carefully adhere to the treatment regimens  so as to prevent drug resistance 
and improve on survival. 
 
Antiretroviral treatment is complex as it is influenced by several factors and because of 
its complexity, Skovdal, Campbell, Nhongo, Nyamukapa and Gregson (2011a:297) 
recommended the need to carry out more studies that would identify factors that 
influence ART adherence. Zuurmond (2008:4) identified  availability of food, maintaining 
good nutrition, availability of a strong supportive family and support group meetings for 
people living with HIV and AIDS as some of the factors that can influence adherence to 
ART. Stigma attached to HIV which sometimes prevented patients from taking the 
ARVs from public institutions, high costs of ARVs, inaccessibility of ART clinics and 
sometimes poor quality of ART service delivery were some of the factors that 
contributed to non-adherence to ART (Zuurmond 2008:11).  According to Jean-Baptiste 
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(2008:16), the most common reasons for non-adherence was due to forgetfulness, 
competing priorities, away from home during the scheduled time, depression and 
minimal support from family and friends. 
 
A study from Ayalu et al (2011:2) revealed lack of HIV disclosure to children had 
negative influence on adherence to ART as some children refused to take the 
medicines. Other factors such as stigma, high user fees, failure to notice change in one 
health status and interruption of supply of antiretroviral drugs greatly contributed to non-
adherence in most developing countries (Posse, Mehew, Van Asten, Van Der Ven & 
Baltussen 2008:905; Ayalu et al 2011:2). 
 
Despite the fact that some African countries had resource constraints high levels of ART 
adherence were noted in these poor resource settings (Campbella, Skovdal, 
Mupambireyi, Madanhire, Nyamukapa & Gregson 2012:123).  Zimbabwe was among 
these countries that had good adherence levels (Campbella et al 2012:129), however, 
barriers such as poor service delivery, high service charges, limited support from family 
members, shortage of trained health workers and poor nutrition were some of the 
challenges that needed to be addressed.  
 
In Nepal, Wasti, Randall, Simkhuda and Teijlingen (2011:40) identified ethnic and 
cultural beliefs as a barrier ART adherence, as the Nepalese culture did not allow open 
discussion about HIV and AIDS hence there was promotion of stigma and discrimination 
which adversely affected their adherence to ART. However, Wasti et al (2011:43) 
viewed ART adherence as a management issue between ARV receivers and health 
care providers where the decision to adhere is merely the choice of the patient which 
can be influenced by ones cultural or religious beliefs. 
 
1.3 THE RESEARCH PROBLEM 
 
Strict adherence to treatment instructions is critical for successful suppression of the 
immunodeficiency virus but maintaining high levels of adherence levels has been seen 
as a challenge some settings (Skovdal et al 2011a:297). It was also noted that there 
was an exponential increase in the number of people in need of ART after WHO 
recommended to commence HIV patients with a CD4 cell count of 350 and below 
regardless of their WHO clinical staging (Ministry of Health and Child Welfare 
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2009b:24). Zimbabwe recorded the highest rise in enrolment, with an increase of almost 
50% in the number of people receiving treatment between December 2009 and 
December 2010 (WHO, UNICEF & UNAIDS 2011:98), the problem is how to maintain 
the high levels of adherence required for maximum viral suppression. Generally it is 
known that drugs do not work in patients who are not consistent with the treatment 
(Osterburg & Blaschke 2005:487). Patients with chronic conditions sometimes fail to 
adhere to the prescribed treatment and the problem now extents to people living with 
HIV (PLHIV) on ART who are also now classified as chronic  after the introduction of 
antiretroviral therapy. Furthermore ART is a complex treatment which requires timely 
and daily administration of the drug and that can only be possible if there is commitment 
and participation from the individuals coupled with other necessary support (Skovdal et 
al 2011a:301). For one to fully enjoy the benefits of the antiretroviral treatment, a 
minimum adherence level of 95 % or greater is needed to maintain undetectable viral 
loads among patients treated with highly active antiretroviral therapy (HAART) but this 
has not been possible with some patients (Jean Baptiste 3008:5).  In 2011, poor 
adherence levels were reported in poor African countries where about 25% of the ARV 
users, were still struggling to adhere and were at risk of clinical progression and drug 
resistance (Skovdal et al 2011a:296). If a patient develops resistance to first line of 
antiretroviral therapy this may warrant shifting to second line therapy (Zuurmond 
2008:5) which may be very expensive and sometimes very difficult to access. The 
problem of drug resistance was also reported in the Zimbabwe Herald (Zimbabwe 
Records HIV Treatment Failure 2012:1) where almost 8 000 Zimbabweans living with 
HIV could not be treated after they developed resistance to the first line of antiretroviral 
drugs. 
 
Although no challenges were encountered in accessing the treatment as ART clinics 
were rolled out throughout the country, what is required now is to ensure that the 
individuals on ART maintain high levels of adherences. Skovdal et al (2011a:297) also 
argued that the success to ART should not only be measured by the total number of 
clients on ART alone, but should also consider the number of patients who strictly 
adhere to this lifelong treatment.  
 
In view of the continuous increase in number of patients on ART, coupled with reported 
poor adherence levels and increased cases of drug resistance, there is need to explore 
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deeply factors that may facilitate high levels of adherence from the individuals who had 
the experiences of taking ART. 
 
1.4 AIM OF THE STUDY 
 
The study aims to explore the factors contributing to adherence of ART among adult 
patients attending ART clinic at Beatrice Infectious Disease Hospital (BRIDH). The 
hospital is a public health institution owned by City of Harare is situated in Mbare high 
density suburbs in Harare. 
 
1.4.1 Research purpose 
 
The purpose of the study is to explore individual level factors and explain events as 
close as possible to the lived experience of the individual. 
 
1.4.2 Research objective 
 
• To explore individual level factors that promote adherence to antiretroviral 
treatment within the programme, socio-cultural and service delivery context 
among clients attending ART clinic in Zimbabwe. 
 
1.4.3 Research question 
 
• What are the various facilitators that promote ARV adherence from the patients’ 
perspective? 
 
1.5 SIGNIFICANCE OF THE STUDY 
 
The study explored factors that influenced individuals to adhere to antiretroviral therapy 
and also explored factors surrounding the individual that would be implemented to 
increase patients’ adherence levels. Maintaining high adherence levels would make 
patients enjoy fully the benefits of ART when they realise improvement in their quality of 
life. There will also be reduction of mortality and morbidity due to AIDS thereby 
lessening the number of orphaned children due to HIV and AIDS. Furthermore, if high 
levels of adherence are maintained patients will continue on first line therapy which is 
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much cheaper and the burden of switching over patients to second line therapy as a 
result of drug resistance will be reduced. 
 
1.6 DEFINITIONS OF KEY CONCEPTS 
 
1.6.1 Adherence 
 
Adherence in this study is defined as the extent to which patients take medications as 
prescribed by their health care providers (Osterburg & Blaschke 2005:487). 
 
1.6.2 Adult 
 
An adult is a person older than 19 years of age unless national law defines a person as 
being an adult at an earlier age (WHO 2013:13).  In Zimbabwe an adult is referred to a 
person who has attained the legal age of maturity (Parliament of Zimbabwe 1982). In 
this study adult refers to a person who has attained 18 years and above.  
 
1.6.3 AIDS 
 
Acquired Immunodeficiency Syndrome (AIDS) is defined as a fatal disease caused by 
HIV virus, the HIV virus destroys the body’s ability to fight off infection and disease 
(UNAIDS 2009:7). 
 
1.6.4 Antiretroviral therapy 
 
Antiretroviral therapy is any combination of drugs that have the primary intent to prevent 
the progression of AIDS (Posse et al 2008:905).  
 
1.6.5 CD4 cell 
 
CD4 cell is a type of T-cells involved in protecting against viral, fungal and protozoa 
infections. Destruction of CD4 is the major cause of immunodeficiency observed in 
AIDS (Cichocki 2008:1). 
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1.6.6 Factor 
 
In this study a factor is defined as an independent variable (Wikipedia 2013). 
 
1.6.7 First line therapy 
 
First line therapy in this study is defined as most common antiretroviral drug 
combination given to those beginning treatment consisting of two Nucleoside Reverse 
Transcriptase Inhibitors combined with an Non-nucleoside reverse transcriptase 
Inhibitors or a boosted protease inhibitor (Avert 2012). 
 
1.6.8 Influence 
 
Influence in this study is defined as the capacity or power of a person or things to be a 
compelling force on or produce effects on the actions, behaviour or opinion (The 
American Heritage Dictionary of the English Language 2009).  
 
1.6.9 Non-adherence 
 
Non-adherence in this study is defined as when one misses doses completely, as well 
as taking drugs inappropriately, that involves taking doses at the wrong times or not 
adhering to dietary requirements associated with a drug (Jean-Baptiste 2008:5). 
 
1.6.10 Second line therapy 
 
Second line therapy in this study is referred to as drugs given to a person if HIV 
becomes resistant to the first line combination or if side-effects are particularly bad and 
include a minimum of three new drugs, with at least one from a new class (Avert 2012). 
 
1.6.11 Viral load 
 
Viral load is a measure of the severity of viral infection and can be calculated by 
estimating the amount of virus in an involved body fluid and also indicates the efficacy 
of the medication (Cichocki 2007:1). 
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1.7 META THEORETICAL ASSUMPTIONS 
 
In this study it was assumed that information given by participants through in-depth 
interviews would be a true reflection of what makes one to adhere. Furthermore, it was 
assumed that participants would not give social desirable answers but only the truthful 
answers basing on their experiences. Sometimes participants may be suspicious and 
want to please the researcher by giving inaccurate answers that may lead to bias 
(Joubert & Ehrlich 2007:108).  
 
1.8 RESEARCH DESIGN AND METHODS 
 
The design of the study, methods, sample selection and data collection methods will be 
discussed. 
 
A qualitative study, descriptive phenomenology, was conducted as it was the most 
suitable design to use when a problem or issue needs to be explored (Creswell 
2007:39). Use of descriptive phenomenological approach allowed participants to 
describe their experience of things as they experienced them and these included 
hearing, seeing, believing, feeling, remembering, deciding, evaluating and acting (Polit 
& Beck 2012:495). The qualitative design method used by the researcher made it 
possible to explore and understand the meaning of individuals ascribed to a social or 
human problem (Creswell 2009:4).  Face to face interviews are most suitable when one 
requires to explore multiple realities that are based on the actual words of participants 
(Creswell 2007:18).  In this study the researcher conducted face to face interviews 
where multiple realities were identified basing on the actual words of participants. 
 
The study population comprised of HIV positive adults on antiretroviral therapy 
attending antiretroviral therapy clinic at Beatrice Road Infectious Disease Hospital 
(BRIDH) in Harare. Non-probability sampling was applied. The participants were 
identified through purposeful homogenous sampling. The inclusion criteria comprised of 
clients above 18 years attending ART clinic at BRIDH with the following characteristics: 
 
• Confirmed HIV positive diagnosis 
• Currently taking ARV treatment 
• Has been taking ARV treatment for at least three months 
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• Able to provide informed consent 
 
Only those who met the inclusion criteria participated. Data was collected through in- 
depth interviews with the aid of a semi-structured interview guide. Detailed notes were 
taken and the conversations were also audio-taped. 
 
Data was analysed so as to elicit meaning from the data. The data was manually 
analysed. Information from field notes were cross checked with verbatim responses of 
the participants and also stored electronically. The audio tapes were transcribed into 
text and stored the information electronically as word document. The researcher read 
through the transcripts several times so as to get an understanding of the responses 
from the participant and to search for themes and segments. Common themes that 
facilitate adherence to antiretroviral therapy were identified. 
 
1.9 SCOPE OF THE STUDY 
 
The study was limited to only one hospital in Harare, Beatrice Road infectious Disease 
Hospital. 
 
1.10 STRUCTUREOF DISSERTATION 
 
Chapter 1 gives an orientation of the study where background, research problem, aims 
and objectives, significance of study were discussed. 
 
Chapter 2 comprises of detailed information on literature review. 
 
Chapter 3 covers information on research design and methods used. 
 
Chapter 4 addresses findings of the study and the discussions section. 
 
Chapter 5 covers the conclusion, limitations and recommendations that can improve the 
ART programme. 
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1.11 CONCLUSION 
 
In this chapter the background information, the research problem, aim and objectives, 
definition of terms and significance of study was discussed. A summary of the research 
design, research methods and data analysis was discussed. 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
 
2.1 INTRODUCTION 
 
The aim of this chapter is to have a better understanding of the factors which affect 
adherence to antiretroviral treatment (ART). Literature review is conducted by 
researchers to determine how best to make a contribution to existing evidence and it 
also guides the researcher at the end of the study to assess if the findings are similar 
with other researchers’ findings (Polit & Beck 2012:95). There have been numerous 
studies aiming to identify and improve factors that can facilitate ART adherence after 
realisation of the central role played by adherence in success of ART (Wekesa 2007:1).  
From the literature review there has been an overwhelming amount of evidence from 
clinical trials published which validated the use of ART as the only treatment known so 
far that suppresses HIV. 
 
This chapter will discuss HIV pathology, HIV screening methods, HIV treatment, 
benefits of ART, overview of the ART programme, measurement of ART adherence and 
review literature on previous studies done on ART adherence.  
 
2.2 HIV PATHOLOGY AND MODE OF TRANSMISSION 
 
HIV was unknown until early 1980s and since then millions of people have been 
affected (Klaat 2013:6). The most affected age group are young persons aged between 
15-24 years and this has affected the natural economies of the countries because of the 
loss of young to middle aged who are economically productive (Klaat 2013:6). When the 
HIV enters the bloodstream it attacks the white blood cell called T-Helper lymphocytes 
which are essential to the functioning of the immune system (Shaw 2013). Damage to 
the immune system, which is marked by depletion of the CD4 T-lymphocytes, exposes 
the infected person to opportunistic infections and malignancies (Shaw 2013). 
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HIV is transmitted from one person to another through the contact of body fluids (Klaat 
2013:26) and mothers who are infected with the HIV can pass the virus to their babies 
during pregnancy, at time of delivery through the birth canal or through breast milk.  A 
person may take approximately 6 to 8 weeks to seroconvert to HIV positive status after 
contracting the infection and it is also estimated that one can live up to 8 to 10 years on 
average without treatment, before developing the clinical signs and symptoms of AIDS 
(Klaat 2013:26). There may be a risk of these HIV infected persons spreading the 
infection unknowingly as  most of them  are asymptomatic and do not seek  medical 
treatment. 
 
2.3 HIV SCREENING METHODS AND TESTS 
 
People infected with HIV cannot be recognised by appearance alone, since some of 
them will be asymptomatic during the early stages, therefore as a strategy to reduce 
new HIV infection,  all people are encouraged to have an HIV test even if one is well 
(Ministry of Health and Child Welfare 2009b:6). Most commonly used two types of HIV 
screening methods consists of the Rapid HIV testing and the Conventional HIV testing 
algorithm (CDC 2009). In Zimbabwe, the Rapid test method is the most frequently used 
(Ministry of Health and Child Welfare 2009b:6). HIV testing services were scaled up 
through the national roll out of the Provider Initiated HIV Testing and Counselling 
programme (Ministry of Health and Child Welfare 2009b:6). The rapid test is the most 
commonly used because of its convenience  as it can be performed at the point of care, 
test is simple to perform, requires minimal equipment and results are made available 
within 10-30 minutes (CDC 2009). However, because of the limitations of the rapid test 
as it indicates the presence of antibodies only, a confirmatory test such as Western blot 
or Immunofluorence Assay (IFA) may be required to confirm the presence of HIV (CDC 
2009). A window period of 8-12 weeks following infection is put into consideration, 
therefore a second confirmatory test is done after the window period. 
 
2.4 HIV PREVENTION METHODS AND STRATEGIES 
 
Zimbabwe adopted HIV prevention strategies aiming at reducing or preventing the 
spread of HIV (NAC 2011:26).  Among the interventions employed in Zimbabwe were 
behaviour change communication, condom promotion, voluntary male circumcision, 
prevention of mother-to-child transmission of HIV (PMTCT), HIV testing and 
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counselling, prevention and control of sexual transmitted diseases, blood safety and 
post exposure prophylaxis (PEP) (NAC 2011:26).  
 
HIV testing and counselling is one of the preventive strategies rolled out nationally. The 
strategy plays a vital role in HIV prevention as it enables people to know their HIV 
status, thereby enabling them to seek early treatment and practice safe sexual 
behaviours (NAC 2011:31). 
 
The Prevention of Mother to Child Transmission of HIV (PMTCT) is major prevention 
strategy adopted aiming at preventing the vertical transmission of HIV from mother to 
child (Ministry of Health and Child Welfare 2009b:9). This is achieved through 
administration of a course of antiretroviral drugs given to HIV positive women during 
pregnancy and during labour as well as their newborns (Avert 2013b:1). 
 
Blood safety is one of the most effective strategies for preventing HIV transmission. HIV 
thrives in human blood therefore thorough screening of all blood and blood products 
and use of sterile needles and syringes is mandatory (NAC 2011:36).  
 
Correct and consistent use of condoms is one of the HIV prevention methods (NAC 
2011:28). Male circumcision is also an important element of HIV prevention. Studies 
have shown that male circumcision can reduce the probability of HIV infection in an HIV 
negative male by 60% (NAC 2011:30). The strategy was taken positively in Zimbabwe 
where 700 men requested to be circumcised within two weeks of the government 
starting the roll out of voluntary medical male circumcision (VMMC) services for HIV 
prevention (Avert 2013a:1).  
 
Social and behaviour change communication is key to adopting HIV prevention 
strategies (NAC 2011:26). The strategy includes comprehensive sex education 
involving training in life skills, information on how to practise safe sex and negotiating 
healthy sexual relationships is an essential part of HIV prevention (NAC 2011:26).  
 
Post exposure prophylaxis (PEP) is a special course of HIV treatment prescribed to 
people who have been exposed to the virus. The course is administered with an aim of 
preventing the exposed person to HIV infection, therefore it is administered soon after 
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one has been exposed to the infection and this mainly occurs at work or through sexual 
abuse (NAC 2011:37). 
 
2.5 HIV TREATMENT 
 
There is no cure for HIV and AIDS. Although a variety of therapies  such as bone 
marrow transplantation, lymphocyte transfusions, thymic transplantation and therapeutic 
aphaeresis were tried to remove the virus  they were not successful and are no longer 
employed (Klaat 2013:47). In the absence of cure, antiretroviral treatment is the only 
option that offers a dramatic reduction of the virus in an infected individual (Wekesa 
2007:1). The aim of antiretroviral treatment is to reduce the amount of HIV in the body 
to a point where it is no longer possible to detect  in the blood as it diminishes viral 
replication thereby reducing destruction of the immune system (Klaat 2013:48; WHO 
2006:24). CD4 cell count is frequently checked for all patients on ART to assess the 
viral load as this is the most important indicator of response to ART ( HSS Panel on 
Antiretroviral Guidelines for Adults & Adolescents 2013:26).  
 
There are many kinds of antiretroviral drugs that attack the virus in different ways and 
for this reason the treatment entails use of combination of antiretroviral drugs and taking 
a combination of two or more antiHIV drugs is referred to as Highly Active Antiretroviral 
Therapy (Avert 2012:1). However, these antiretroviral drugs can only reduce the viral 
load as they stop virus multiplication therefore do not completely eliminate the HIV virus 
from the infected person (Klaat 2013:48). The most commonly used drug combination 
given to those beginning treatment consists of two Nucleoside/Nucleotide Reverse 
Transcriptase Inhibitors (NRTI) with either a Non-Nucleoside Reverse Transcriptase 
Inhibitors (NNRTIs) and a boosted protease inhibitor (Avert 2012:1). HIV copies its own 
genetic code into the cell DNA when it enters the body. NNRTIs contain several 
medicines that aim to control the amount of virus in the body by preventing replication of 
the virus by primarily blocking HIV-1 replication (Sluis-Cremer & Tachedjian 2008:1). A 
combination of drugs that a person is given at the beginning is called first line therapy, 
then if HIV becomes resistant to this combination then a change to second line therapy 
is recommended (Avert 2012:1). A combination of first line drugs may include Tenofovir, 
Disoproxil Fumarate and Lamuvidine or Emitricitabine (WHO 2013:30). Some of the 
common side effects that may occur from these ARVs include severe skin reactions, 
convulsions, liver damage, central nervous system toxicity such as abnormal dreams, 
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depression or mental confusion (WHO 2013:139). Antiretroviral drugs have different 
side-effects and these may have an impact on how the patients take the drugs (WHO 
2006:24). 
 
In some countries several ARVs are combined in a single dose tablet, fixed dose 
combination (FDC) which ensures that a patient takes multiple doses together which is 
more convenient for the patient.  
 
2.6 OVERVIEW OF THE ART PROGRAMME 
 
HIV and AIDS is one of the leading cause of deaths in Sub-Saharan Africa (WHO, 
UNICEF, UNAIDS 2011:2). In response, Sub-Saharan Africa, being the region most 
affected by the epidemic had the greatest increase in the absolute number of people 
receiving treatment in 2010 where a total of 3 911 000 were reported  in December 
2009  and the number rose to about 5 064 000 in 2010 (WHO,UNICEF,UNAIDS 
2011:97). Twenty countries in Sub-Saharan Africa accounted for 84% of the people 
receiving ART in 2010 (WHO, UNICEF, UNAIDS 2011:97) and countries in Southern 
Africa being the worst affected. South Africa had the greatest absolute number of 
people living with HIV and due to rapid ART scale up the country managed to provide 
antiretroviral therapy to almost one fifth of all people receiving ART (WHO, 
UNICEF,UNAIDS 2011:98). In terms of percentage, Zimbabwe recorded the highest 
rise in enrolment, with an increase of almost 50% in the number of people receiving 
treatment between December 2009 and December 2010 (WHO, UNICEF, UNAIDS 
2011:98).  
 
Globally ART coverage increased tremendously in 2011, where 8 million people were 
reached with ART services, a 20 fold increase since 2003 (UNAIDS 2012a:50). The 
issue of concern now is how to maintain high rate of adherence. It was observed that 
most patients discontinued ART mostly during the first year of starting therapy (WHO, 
UNICEF & UNAIDS 2011:89) and patient’s retention rate decreased as the period of 
treatment increased. In 2010, WHO, UNICEF and UNAIDS (2011:85) reported global 
retention rates of 81% occurring within 12 months after initiation of treatment, 75% after 
24 months and 67% after 60 months. 
 
  
16 
Zimbabwe was among the countries in Southern Africa worst affected by HIV and AIDS 
epidemic, however, due to intensive preventive strategies HIV prevalence  declined 
from 23.7% in 2001 to 18.4% in 2005 and 13.1% in 2011 (UNAIDS 2012b:9). This was 
also coupled with the increase in ART treatment coverage which rose from 55% in 2010 
to 79% in December 2011 after adoption of WHO revised guidelines on eligibility criteria 
(UNAIDS 2012b:31). Although success was noted in scaling up of antiretroviral 
treatment, the challenge remains on how to improve and maintain high adherence 
levels among all these people on ART in order to attain successful treatment. 
 
In an effort to improve access and adherence to ART, WHO launched a Treatment 2.0 
initiative to be implemented in resource limited countries with designed priority areas 
and goals for 2020 which  included optimising drug regimens, reducing costs of drugs, 
providing access to point of care, adopting delivery systems and mobilising communities 
(WHO, UNICEF & UNAIDS 2011:91).  
 
2.7 MEASUREMENT OF ART ADHERENCE 
 
Assessment of adherence levels is measured through using various methods. However, 
adherence measurement methods are known to be complex as there is no golden 
standard by which to measure adherence because each methodology has its own 
advantages and disadvantages (Nozaki, Dube, Kakimoto, Yamada & Simpungwee 
2011:7), therefore use of a combination of many methods is recommended. The most 
commonly used methods include patients report of missing pills, pharmacy refill records, 
various self-reporting tools (such as questionnaires and visual analogue scales), 
measurement of assay levels and electronic drug monitors (WHO 2006:27; Chesney 
2012:1). Self-report is the most frequently used measure of adherence to ART because 
it is simple and inexpensive (Nozaki et al 2011:7) but there is need to ensure that 
interviews are done in a relaxed atmosphere where patients feel free to report a non-
adherent event. Although self-report of adherence sometimes tends to overestimate 
adherence the measure remains the most useful method for the assessment of ART 
adherence because of it allows simple reporting of all doses missed during the past 3 
days or past week (HSS Panel on Antiretroviral Guidelines for Adults & Adolescents 
2013:182). Further if a patients report suboptimal adherence this is taken as a strong 
indicator of non-adherence.   
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2.8 BENEFITS OF ANTIRETROVIRAL THERAPY 
 
Introduction of ART services came as a relief to PLHIV as it improved their quality of life 
as well as reducing morbidity and mortality (WHO, UNICEF & UNAIDS 2011:3). It has 
been proved that people living with HIV who have access to antiretroviral drugs and the 
care needed to maintain therapy can live for many years with what is now considered to 
be a complicated but manageable chronic disease (WHO 2006:24). Globally, in low and 
middle income countries 2.5 million deaths have been averted since 2005 (WHO, 
UNAIDS & UNICEF 2011:3), with the majority of the averted deaths in Sub-Saharan 
Africa. It was also proved that half of the people with a CD4 cell of below 350 would be 
expected to die if they did not get antiretroviral treatment (UNAIDS 2012b:50). Some of 
the major benefits realised through the ART treatment were reduction of  risk of sexual 
transmission of HIV virus as the viral load is decreased, many people who were on 
home based care were ambulant and returned to work, parents stay alive longer 
thereby delaying the time when children become orphans (Mbirimtengerenji, Jere, 
Lengu & Maluwa 2013:17). However, these benefits can only be realised only if strict 
adherence to ART is maintained where a high adherence  of over 95% is required to 
suppress HIV replication, meaning that missing more than one dose of a regimen per 
week may be enough to cause treatment failure (Chesney 2012:1). Sustaining this 
lifelong treatment remains a challenge and became even more complicated after 
introduction of Highly Active Antiretroviral Therapy (HAART) because of the complexity 
of the drug regimens (Chesney 2012:1).  
 
2.9 FACTORS THAT INFLUENCE ADHERENCE TO ART 
 
Identification of principal factors contributing adherence to ART treatment ensures 
appropriate implementation of strategies and measures to improve adherence even 
prior to initiation of ART treatment. HSS Panel on Antiretroviral Guidelines for Adults 
and Adolescents (2013:182) also recommended provision of appropriate resources and 
strategies that would help a patient to achieve and maintain good adherence such as 
prescription of regimens that are simple to take, dealing with patients psychosocial 
needs, learning needs and availability of a multidisciplinary trusting health care team 
even before treatment is initiated.  Some of the factors that influenced adherence 
identified in Zimbabwe were implementation of the task shifting policy, training more 
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health workers on ART, reducing waiting hours and provision of ART related costs 
(NAC 2011:38). 
 
From the literature review it is clear that factors that influence a patient’s ability to 
adhere are multiple and complex, hence need to explore them and come up with 
strategies that promotes adherence to ART. The factors will be discussed in four 
categories and these entail factors related to the individual/patient, drug regimen 
factors, socio-cultural factors and service delivery related factors. 
 
2.9.1 Patient-related factors 
 
Prior to commencement on ART there are certain requirements that should be 
assessed to ensure patients readiness to take medication, as it is necessary to identify 
and deal with factors that may limit adherence to ART (HSS Panel on Antiretroviral 
Guidelines for Adults & Adolescents 2013:182).  Adherence facilitators  pertaining to 
patient include individualising treatment plan, increased knowledge on adherence, 
counselling sessions, missing appointments, housing, age, forgetfulness and reminders, 
competing priorities, literacy level, food, alcohol abuse, depression, counselling, 
provision of ART related costs, marital status, religion, improvement in the general 
status of health and short waiting time. 
 
Involving patients in making the treatment plan ensures better adherence. A patient 
centred approach which  entailed individualising treatment plan with the involvement of 
the patient in decision making, continuous assessment of adherence factors and 
tailoring adherence interventions to suit the individual was seen as a  cornerstone to 
ART adherence (HSS Panel on Antiretrviral Guidelines for Adults & Adolescents 
2013:183). 
 
Continuous assessment of adherence at every clinic visit may help identify reasons why 
patients sometimes failed to adhere to treatment scheduled times and sometimes miss 
appointments. A study conducted in Uganda which assessed adherence levels revealed 
that those who missed appointments had travelled  and also some of the main reasons 
identified for missing doses were due to forgetfulness, work conflict and felt unwell 
(Shumba, Atuhaire, Imakit, Atukunda & Memiah 2013:2).  Transport challenges were 
cited as one of the main barriers to adherence because when patients failed to reach 
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ART clinics for their pharmacy refills they also miss clinic appointments and are likely to 
miss their doses as well if they did not have enough supply (Shumba et al 2013:4). 
 
As a strategy to improve adherence Ministry of Health and Child Welfare (2011:32) 
recommended monitoring of ART adherence and identification of early warning signs for 
possible drug reaction. The strategy entailed monitoring percentage of ART patients 
picking up prescribed ARV on time and percentage of ART patients attending all clinic 
appointments on time (Ministry of Health and Child Welfare 2011:32). This ensured 
timely follow up on those who missed appointments. 
 
Assessment of housing and home situation was found to be critical prior to 
commencement of ART as unstable housing is associated with missing appointments 
and loss to follow up. A study conducted by Mendelsohn, Schilperooid, Spregel and 
Ross (2012:6) revealed that ART adherence was disturbed in conflict areas where 
patients were not able to access ART health facilities, hence this resulted in them 
missing their appointments and some were lost to follow-up. 
 
Age of a person is another factor that influenced adherence to ART.  According to 
Nyambura (2009:54) ART adherence was seen to increase with increasing age and 
decreased as the age advances beyond 60 years. With the young population ART 
adherence was mostly affected by stigma and denial, whilst with the elderly senile 
dementia  influenced their understanding on adherence issues therefore had challenges 
in following ART instructions (Nyambura 2009 :54).  
 
Forgetfulness was identified as a major contributing factor to non-adherence, as such 
reminders such as use of mobile phone text messages, cell phones, alarm clocks or 
watches, and calls from health care providers were among some of the methods used 
to improve adherence (Marukutira 2012:70). However, due to competing priorities (such 
as childcare, housing chores, work), some patients ignored reminders and some 
resorted to setting second reminders (Huang, Sangthong, Meilvel, Chongruvivatwong, 
Zheing & Yang 2012:6).  Huang et al (2012:6) further reported some patients who 
ignored phone message reminders from health workers as they preferred to 
communicate with them and obtain more information regarding their treatment.  A study 
in Zambia showed that use of a watch (245, 47% of respondents), use of clock (79, 15% 
of respondents) as the most frequently reported ways to remember when to take ARVs 
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and 49 respondents (10%) reported using the position of the sun to remember when to 
take ARVs (Nozaki et al 2011:4). Maokisa (2011:23) study also showed that 69.4% of 
the patients used clock/cell phone alarms as reminders to ARVs, and it was a very 
convenient way as most people owned a mobile phone for communication.  
 
A study conducted in Vietnam by Do (2011:130) showed marginally significant 
association between lower education level and non-adherence, p=0.06. However, 
recommendations were made not to ignore these individuals, but establish strategies to 
accommodate these few individuals who have difficult in reading and understanding 
medical instructions. 
 
Failure to secure enough food contributed to non-adherence to ART. Good nutrition is 
required by patients on ART to enable them to  mount an effective immune response,  
hence the need to provide patients on ART with the necessary food requirements so as 
to promote adherence (NAC 2011:39). Lack of food contributed to low ART adherence 
particularly during the initial stages of ART when the body needs extra nutrition (WHO 
2006:9). Failure to secure enough food forced some patients to take their medicines 
once a day in the evening instead of twice because that was the only time they got food 
(WHO 2006:9). Furthermore, NAC (2011:39) reported that the high mortality which 
occurred during the first 90 days of ART treatment was found to be associated with 
failure to get good nutrition. 
 
Alcohol abuse, difficulties in integrating HAART to one’s lifestyle, and psycho-emotional 
issues such as depression and hopelessness, or lacking the will to live with HIV were 
some of the factors that affected patient’s adherence to ART treatment (Chizanga 
2010:155, Chesney 2012:1, Do 2011:132, Shumba et al 2012:3, Maokisa 2011:7). 
Although directly observed therapy (DOT) was seen as an effective strategy used in 
provision of ART to drug active users, the strategy was seen to be unsustainable (HSS 
Panel on Antiretroviral Guidelines for Adults & Adolescents 2012:182). 
 
Providing information to the patients about their condition and treatment is critical to 
enable patients to have informed decisions about their treatment (Nunes, Nelson, 
O’Flynn, Calvert, Kuntze, Smithson, Benson, Blair, Bouser, Clyne, Crome, Hemingway, 
Home, Johnson, Kelly, Packham, Patel & Steel 2009:9). Series of adherence 
counselling sessions which offer information to patients about their condition, treatment, 
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significant side-effects, and what to do if side-effects occur, what to do if they miss a 
dose and how to get further supply were identified as important factors that influenced 
patients adherence to ART (Nunes et al 2009:11). Mendelsohn et al (2012:82) also 
identified quality counselling from trained counsellors as a key requirement for 
successful ARV adherence.  A study by Maokisa (2011:35) also revealed continuous 
education as one of factors that promoted adherence. 
 
Chance health locus of control was also found out to be significantly associated with 
non-adherence (Do 2011:153). Implication of this finding suggested that health 
education and counselling given to HIV/AIDS patients should emphasise the harm the 
belief that chance or luck determines patient’s health outcomes, as this belief may 
negatively influence their adherent behaviour (Do 2011:153).  
 
Sometimes adherence is related to challenges faced by individuals in obtaining 
adequate resources required to enable them to adhere to the required treatment 
prescriptions (Nunes et al 2009:1). Therefore provision of other ART treatment related 
costs was found as an essential factor that contributed to ART adherence. Even though 
ARVs are supplied free at government hospitals, as they are sponsored by The Global 
Fund to Fight AIDS, TB and Malaria and United States Emergency Plan for AIDS Relief 
(WHO, UNICEF,UNAIDS 2011:98), it was found that some patients could not afford 
other costs such as transport costs, clinic fees and other hidden costs (Bemelmans, 
Akker, Ford, Phillips, Zacharia, Hamer, Schoouten, Hermann, Mwagomba & Massaqoui 
2010:6, Maokisa 2011:32). WHO (2006:13) also identified hidden costs such as lost 
wages due to frequent clinic visits, clinic registration, user fees at private health facilities 
and long waiting hours  as some factors that needed to be addressed so as to promote 
adherence.  
 
Masculinity was seen to interfere with married women’s adherence to ART. A study 
done in Zimbabwe revealed that most men denied being associated with HIV as they 
wanted to protect their manhood and they viewed HIV and AIDS as a threat to 
masculinity and to them being ill belittles their sense of manhood (Skovdal et al 
2011b:3). Furthermore, some men when they discovered that their wives were on ART, 
they denied them permission to take their drugs or sometimes steal their drugs for their 
own treatment (Skovdal et al 2011b:2). Such actions consequently affected women’s 
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adherence to ART as they failed to get the supportive treatment required and ended up 
taking their medication secretly. 
 
Religion plays an important role in influencing ART adherence levels although 
sometimes negative influences from the religious sector were identified, as such during 
adherence counselling sessions addressed religious beliefs and practices that may 
hinder adherence to ART (Maokisa 2011:32). A study by Mbirimtengerenji et al 
(2013:20) revealed that Christians adhered better to ART than any other religions. In the 
same study Mbirimtengerenji et al (2013:21) also noted non adherence in some strong 
religious believers who believed that God has supernatural powers and healed HIV and 
AIDS therefore discontinued treatment. 
 
A study by Mbirimtengerenji et al (2013:21) revealed that patients who were self 
employed or had their own businesses adhered better than those who were formally 
employed because they were self-governed on the time they go for refill whist the 
formally employed may sometimes miss appointments when they were denied the time 
off by their employers to go for their monthly refills.  
 
ART adherence requires one to adhere to the schedules but in some instances this 
might not be possible. Do (2011:149) cited factors such as being too busy, special 
events changing daily schedule, travel and oversleeping among others as factors that 
prevented PLHIV from taking their ARVs. 
 
Patients on ART who noted improvement of their general health status were motivated 
to keep all the appointments and not to miss a dose as they could see that ART made a 
difference in their quality of life (Mbirimtengerenji et al 2013:24; Maokisa 2011:35). 
 
2.9.2 Service delivery factors 
 
Quality service delivery provided by a multidisciplinary health team influenced 
adherence to ART as the services were  delivered in the context of a comprehensive 
care that addressed medical, social and emotional needs of PLHIV (Campbell, Scott, 
Madanhire, Nyamukapa & Gregson 2011:1). Some of the service delivery factors that 
promoted ART adherence  identified by Campbell et al (2011:1) were provision of  
adequate manpower, accessible ART clinics, motivated health workers, removal of user 
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fees, good nurse patient relationship, maintaining a regular health service provider 
increases adherence and short waiting time.  
 
Adequate manpower ensures quality service delivery. Engagement of adequate health 
workers, adoption of strategies that improves service delivery and availing services to 
the poor and underserved communities  were some of the factors that improved 
adherence to ART (WHO, UNICEF, UNAIDS 2011:94).  An out-of-clinic model of care 
piloted in Tete province, Mozambique  promoted adherence, as it involved some  
patients in collection of ARVs from ART centres on behalf of other patients, then 
distributed the ARVs to their fellows, monitored adherence levels among themselves 
and offered each other support for adherence  (Decroo, Telfer, Biot, Maiker, Dezebro, 
Gumba, Dores, Chu & Ford 2011:1). The model also helped to decongest the clinics, 
increased adherence, reduced transport costs and reduced loss to follow up as there 
was close monitoring of adherence among the patients themselves (Decroo et al 
2011:4).  
 
Some of the ART services that are too far from the users of services may not be user 
friendly thereby making it impossible for some patients to meet their monthly 
appointments. Therefore bringing ART clinics to accessible points ensures access, 
reduces transport costs, promotes adherence and ensures adequate monitoring (WHO, 
UNICEF, UNAIDS 2011:90). A study conducted in Vietnam revealed that people who 
had easy access to ART clinics, that is a distance of less than 10km to clinic, were more 
adherent compared to those living more than 10 km from the clinic (Do 2011:132). 
Those who stayed far sometimes had to borrow money to cover their transport costs, 
and even when they had the money they sometimes failed to get transport from their 
rural homes to the health facility thereby forcing them to miss appointments (Campbell 
et al 2011:5). Similar findings were reported by Charurat, Oyengunie, Benjamin and 
Habib (2010:5). Nozaki et al (2011:6) mentioned that patients who spent long hours 
travelling to treatment facilities incurring expensive travel costs had increased risk of 
non-adherence.   
 
A task shifting model of care that was developed and implemented in Thyolo which 
entails assigning of tasks such as ART refills and adherence counselling tasks to less 
specialised health workers proved to be effective in decongesting ART clinics and in 
making ART clinics more accessible to the community (Bemelmans et al 2010:6).  
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Bemelmans et al (2010:7) further indicated that as a way of attaining maximum 
adherence to ART, models of ART support must be elaborated at community level so as 
to ensure that ART care is made to fit into peoples’ lives, rather than requiring people to 
fit their lives around ART. 
 
Good relationship between patient and health care provider facilitates optimal 
adherence.  ART being a complex treatment require patients to be involved in their 
treatment decisions which entail cordial relationship and open discussions between  
patients and health care providers, focussing mainly on exploring patients decisions 
about the treatment support adherence required (Nunes et al 2009:6). Chizanga 
(2010:164) also reported that patients cope better with their illnesses and adhere more 
to ART if there is an existing friendly and trusting relationship between patients and   
health care providers enables. Campbell et al (2011:5) study also identified  a friendly 
atmosphere displayed by nurses which entails shaking hands, which is a culturally 
accepted way of greeting, taking time to know more about the patients’ lives by listening 
to patients problems and addressing patients religious beliefs as some of factors that 
facilitated adherence to ART. The same study revealed that patients appreciated 
interest shown by staff as they tried to know fully their lives by closely interacting with 
them during every clinic visit (Campbell et al 2011:5). As HIV is now classified as a 
chronic condition where patients frequently visited the ART clinics some patients 
preferred to maintain a regular health provider since they would have developed close 
relationships with particular health care providers (Marukutira 2012:66). 
 
However poor relationships were reported when misunderstandings arose on the 
quantity of supply of ARVs where patients identified good nurses as those who 
prescribed several months of pills at a time and a bad nurse as one who prescribes pills 
for only one month or less (Campbell et al 2011:5).  
 
Patients are less likely to miss appointments if they are attended to within a reasonable 
time. Maokisa (2011:30) study revealed that patients who experienced long waiting 
hours were discouraged from going to the clinics for their monthly reviews and refill. 
Waiting for long hours is stressful and sometimes it can be worsened by poor 
interpersonal communication between patients and health care providers, where 
patients were sometimes asked to sit down on the floor when benches were all 
occupied (Campbell et al 2011:5).   
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2.9.3 Factors related to medication 
 
Medication related factors that promote adherence entails prescription of regimens that 
are simple to take, with minimal side-effects, medication with no food restrictions and 
prevention of drug stock outs. Among some of the factors that were seen to influence 
adherence were issues related to size of pill, number of pills, side-effects, food 
restrictions as well as dosing times had a negative influence on adherence (Marukutira 
2012:75). In addition to the number of pills, antiretroviral treatment users are expected 
to take their doses at the same regular intervals for life and follow dietary requirements 
which might not be an easy task. 
 
Patients adhere better to medications with low incidence or less side-effects, regimens 
that are simple to take, have a low pill burden and low frequency dosing (HSS Panel 
Antiretroviral Guidelines for Adults & Adolescents 2013:182). Side-effects from 
antiretroviral medication were one of the most common factors that contributed to non-
adherence to treatment (Do 2011:139). When patients experienced side-effects some 
skipped their doses whilst some completely stopped treatment despite the fact they 
were given relevant information about the discomfort (Maokisa 2011:9). Some of the 
reported side-effects included vomiting, swollen legs, increased heart rate, nausea, 
anaemia, headache, skin rashes and dizziness (WHO 2006:11). It was also noted that 
additional medications taken for symptomatic relief such as TB drugs, Cotrimoxazole, 
cough remedies and other medications used for symptomatic relief further added to the 
pill burden (Nyambura 2009:60). 
 
Reports of Adverse drug reaction reports from Medicines Control Authority of Zimbabwe 
(MCAZ), a body which monitors safety of drugs, indicated that majority (94%) of the 
reports were drug reactions due to ARVs, about 42% were due to one drug, Stavudine 
toxicity (Ministry of Health and Child Welfare 2009a:67). In response WHO 
recommended phasing out the use of Stavudine because of its long term toxicity and 
side-effects and it was substituted with a less toxic drug (WHO, UNICEF & UNAIDS 
2011:112).  
 
Uninterrupted supply of ARVs contributes to ART adherence. A study done in Zambian 
rural areas revealed that non adherence was strongly associated with stock outs of 
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ARVs, and  some patients were pressured to share ARVs with a family member or a 
friend  until the other person secures his/her supply (Nozaki et al 2011:6).  This created 
another problem as the other person would quickly run out of supply and this adversely 
affected adherence level (Nozaki et al 2011:6), hence need to ensure an uninterrupted 
supply of ARVs so as to minimise the emergency of drug resistance and promote 
adherence.  As a strategy to prevent drug stock outs WHO recommended a set of 
harmonised monitoring and evaluation indicators to be monitored for procurement and 
supply of antiretroviral drugs ((WHO, UNICEF & UNAIDS 2011:105).  Zimbabwe was 
among the countries that conducted a pilot test on drug procurement and management 
and  the results demonstrated that procurement and supply management indicators, if 
monitored well can increase the performance of national procurement and supply 
management system (WHO, UNICEF & UNAIDS 2011:108), thereby promoting 
adherence. Furthermore, timely supply of ARVs was also ensured by monitoring the 
indicator on the percentage of health facilities dispensing ARVs that experienced a main 
pharmacy stock out of  at least one required ARV in the last 12 months (Ministry of 
Health and Child Welfare 2011:30). 
 
2.9.4 Socio-cultural factors 
 
Family and community support, disclosure of one’s HIV positive status and cultural 
issues plays a vital role in adherence to ART. Support from the community proved to 
enhance adherence to ART and also helped in retention as revealed in a study 
conducted in Tete, Mozambique that engaged community ART groups in ART 
distribution and monitoring (WHO, UNICEF & UNAIDS 2011:96). Also peer support and 
self-help groups (known as Friend help Friend) were found to be very effective in 
helping PLHIV to access ART and adhere to the regimen (Do 2011:108). 
 
A study done in Botswana showed that most adolescents who had a good adherence 
had support from family (siblings, parents, grandmothers, aunties and caregivers), 
friends and the society (Marukutira 2012:50). Community caregivers also played a vital 
role in adherence support for people on ART as is the practise in Zimbabwe where 
secondary caregivers within the Community and Home Based Care (C & HBC) 
programme provide adherence support and sometimes assist to collect ARV medicines 
from hospital on behalf of clients (Ministry of Health and Child Welfare 2009b:14).  
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Studies have shown that patient cultural beliefs about illness and the efficacy of the 
treatment regimen affect adherence. The way people make sense of illness is partly 
culturally determined and it influences a person’s beliefs to treatment and ethnicity and 
culture were seen to sometimes have constructive or destructive roles for promotion of 
adherence (Wasti et al 2011:5). A study done in Nepal revealed that cultural factors, 
individual beliefs and perceptions about health and seeking treatment affected ART 
adherence as HIV/AIDS was perceived as a bad persons disease (Wasti et al 2011:39). 
As such, Wasti et al (2011:44) recommended modification of the ARV treatment plan to 
fit within the patients cultural beliefs and practices, implement a patient centred 
approach, as it was seen that no one magic bullet helped all ARV patients adhere to 
prescribed regimens. 
 
A major socio-cultural factor which facilitates adherence of antiretroviral treatment is 
disclosure of one’s status as HIV positive and stigma (Do 2011:151). A study conducted 
by Skovdal et al (2011b:1) revealed that HIV stigma and discrimination is still present in 
communities and families despite the positive advantages of antiretroviral treatment 
therefore recommended need to encourage one to be open about the HIV positive 
status. Most participants who failed to adhere to treatment missed their doses as they 
had not disclosed their HIV positive status due to fear of being stigmatised (Marukutira 
2012:66). Nyambura’s (2010:55) study revealed that some women failed to disclose 
their HIV positive status and that they were taking ARVs as they feared  being 
victimised and accused of infidelity or fear that they may be divorced by their husbands. 
To avoid going through such traumatic experiences some patients ended up hiding their 
HIV positive status from colleagues, friends, and relatives, and ended up not adhering 
to treatment (WHO 2006:10). A study done in Nigeria revealed that good adherence 
was associated with disclosure of HIV status and engagement of the community in HIV 
and AIDS care created an environment that reduced stigma and encouraged disclosure 
to family members (Charurat et al 2010:5). 
 
2.10 THE INFORMATION-MOTIVATION-BEHAVIOUR SKILLS MODEL 
 
Health seeking behaviour is dependent on several models. One of the models is the 
Information-Motivation-Behavioural skills (IMB) model and this will be reviewed to 
discuss adherence to antiretroviral treatment. The IBM model of ART assumes that 
adherence related information and motivation are associated with adherence related 
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behavioural skills and these skills directly predict adherence to ART (Amico, Barta, 
Konkle-Parker, Fisher, Cornman, Shuper & Fisher 2011:2). The implication of this 
model translate to the extent that patients on ARVs if well informed, will be motivated to 
take action  and adopt the required behavioural skills to act effectively (Amico et al 
2011:2). Furthermore, Amico et al (2012:2) cited that poor adherence to ART can occur 
when patients are poorly informed, not motivated to take action or lack the required 
behavioural skills to act effectively.  
 
Amico et al (2011:2) emphasised the need to disseminate comprehensive and accurate 
information  as the information comprise of one’s fund of information about HIV and 
AIDS infection, medication adherence, potential side-effects and decision rules 
concerning adherence that may be inaccurate. Poor adherence can also be noted when 
one feels physically well and decide to skip medication (Amico et al 2011:2). A study 
done in the Deep South, Mississippi (Amico et al 2011:5) revealed that adherence to 
ART was not only related to  ones fund of information but also incorporated ones 
behavioural skills. Individual motivation to adhere to treatment regimen plays an 
important role towards antiretroviral treatment adherence where one is personally and 
socially motivated and believe that the antiretroviral treatment adherence can improves 
one’s health (Amico et al 2011:2).  
 
The Behavioural skills component of IBM model of adherence to antiretroviral therapy 
comprises of the specific skills individual must apply to facilitate complex sequence of 
behaviours that are involved in adherence to antiretroviral therapy and ones sense of 
efficacy for applying the skills (Amico et al 2011:2). The required skills, among others, 
entails one’s ability to self-administer combination of ARVs, keep accessible, cope with 
side-effects, stick to prescription schedule, obtain updated information on ART and 
communicate effectively with health care providers and be able to mobilise social 
support for ART adherence (Amico et al 2011:2). 
 
2.11 CONCLUSION 
 
HIV is the leading cause of deaths mainly in Sub-Saharan Africa. In this chapter HIV 
pathology, mode of transmission, HIV prevention methods, ARV treatment and benefits 
of ART were discussed. Literature review on previous studies done on ART adherence 
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was discussed. Factors that facilitate adherence identified in the literature review were 
mainly related to the individual, service delivery, drug regimen and support system. 
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CHAPTER 3 
 
RESEARCH DESIGN AND METHODS 
 
 
3.1 INTRODUCTION 
 
This chapter will present the research methods used for the study. Polit and Beck 
(2012:733) defined methodology as the steps, procedures and strategies for gathering 
and analysing data in a study.  Research design, sampling procedures, data collection 
process and research analysis approaches applied to address the research questions 
will be discussed. The first sections addressed issues to do with the study area and 
setting of the study, sampling procedure followed by data collection and analysis 
methods. The last section deals with issues related to ethical clearance.  
 
3.2 RESEARCH DESIGN 
 
Yin (2009:24) defined research design as the logic that links data to be collected to the 
initial questions of study, hence need to identify a suitable design that can answer the 
research questions. A qualitative study, descriptive phenomenology, was conducted as 
it was the most suitable design to use when a problem or issue needs to be explored 
(Creswell 2007:39).The aim of this study was to explore deeply factors that influenced 
adherence to ART among adult patients attending antiretroviral therapy clinic at 
Beatrice Road Infectious Disease Hospital (BRIDH). The descriptive phenomenological 
approach allowed participants to describe their experiences of things as they 
experienced them and these include hearing, seeing, believing, feeling, remembering, 
deciding, evaluating and acting (Polit & Beck 2012:495). By using the qualitative design 
the researcher was able to explore and understand the meaning of individuals ascribed 
to their social or human problem (Creswell 2009:4). In addition, through face to face 
interviews,  the researcher was able to gather multiple realities based on the actual 
words of participants as they narrated the dynamic experiences of them being HIV 
positive and experiences of taking ARVs (Creswell 2007:18). 
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3.3 STUDY POPULATION 
 
Population is the entire set of individuals or objects having the same characteristic (Polit 
& Beck 2012: 738). The study population was HIV positive adult patients on ART 
coming for review at BRIDH. The hospital serves people from its surrounding suburbs in 
Harare.  
 
The decision to choose this institute was based on the fact that the hospital caters for a 
high number of people on treatment for HIV and AIDS within the suburbs of Harare City. 
An estimate of about 150-200 patients are seen at the clinic on a daily basis from 
Monday to Friday from 7.00 hours to 16.00 hours. 
 
3.4 DESCRIPTION OF STUDY SITE 
 
The study was carried out at Beatrice Road Infectious Disease Hospital (BRIDH) in 
Harare. The hospital is a public health institution owned by City of Harare. It was 
established in 1921 and it is situated in Mbare high density suburbs along Simon 
Mazorodze Road.  
 
The opportunistic infection and antiretroviral therapy (OI & ART) clinic was established 
at this hospital in 2006. Since then the hospital has been offering ART services to adults 
including adolescents. A separate clinic for adolescents was established after a 
realisation that the unique needs of children aged between 12-17 years were not 
addressed at the adult clinic (Gamanya, Mujaji & Nzou 2011:2) Opening of a separate 
clinic for adolescents allowed the adolescents to share their experiences and air their 
concerns in a free environment without adults. Paediatric ART services were also 
introduced in 2009. 
 
The hospital is an initiating centre where patients are commenced on ART, then 
referred to peripheral clinics for monthly review and refills. However, those who default 
treatment are referred back to this hospital for re-assessment by a medical practitioner. 
Also those who are commenced on second line therapy due to treatment failure 
continue to get their medication at the hospital.  
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The hospital has a CD4 testing machine and a laboratory making it easier for patients to 
have all the necessary investigations under one roof. Patients on ART from peripheral 
clinics are referred to this hospital for CD4 count check. It is also a referral centre for 
patients with infectious diseases. It offers other services such as X-rays, TB clinic, 
dental therapy and has medical examination centre. All the patients received ARVs free 
of charge from the hospital pharmacy which is funded by The Global Fund and some of 
it from National Aids Council (NAC). There is a social welfare department where the 
social worker attends to patients with socio-economic problems. Some patients who 
genuinely fail to meet the treatment costs are referred to the social welfare department 
and assisted with free treatment order. Furthermore the ART clinic is attached to a non-
governmental organisation (food programme) that supports the patients on ART with 
food hampers and cash. However the food ration is given to only those who meet the 
eligibility criteria which is based on nutritional screening and only underweight clients on 
ART are eligible to food handouts. Periodic nutritional assessments are done, and if the 
patient’s nutritional status improves the food ration is terminated.  
 
During the monthly reviews health education sessions on HIV and AIDS, antiretroviral 
treatment and adherence are conducted to patients. The interaction also offers 
opportunity for temporary support group meeting where patients share their experiences 
on adherence, share testimonies and have devotional prayers which address their 
spiritual needs. It also serves as an opportunity for questions and answer session where 
patients concerns are addressed. During health education session the idea of 
prioritising daily schedules and giving first priority to clinic appointments was 
emphasised by the counsellor. The counsellor also reassured patients that even if there 
was an emergency such as a family death they should come for their review first and 
staff will save them first, then proceed to the funeral with their medication. 
 
Before patients are initiated on ART they undergo at least three counselling sessions on 
different days. The first counselling session is mainly basic counselling where patients 
are given basic information on HIV and AIDS, self-stigma, acceptance of being HIV 
positive, issues related to disclosure and other basic issues. The second and third 
sessions focus mainly on adherence issues; importance of adhering to ARVs, the 
consequences of not adhering, enabling factors, giving information on ARVs, names of 
ARVs, how they work, side-effects and assessment of readiness to start ART. During 
the subsequent counselling sessions the topics are repeated so as to reinforce 
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knowledge, recapitulation is done with participants and patients are allowed time for 
questions and answers. 
 
More adherence counselling sessions are offered to the patients basing on their 
adherence status during their monthly review visits. The main purpose of the monthly 
reviews is to assess adherence levels and to find out whether patients need more 
information and support. Furthermore the patients undergo relevant investigations such 
as CD4 count which is done to determine if one should be commenced on ART, in 
accordance with WHO guidelines (CD4 count of 350 and below). In the absence of CD4 
count patients are assessed using WHO staging which is based on clinical symptoms.  
 
3.5 SAMPLING 
 
The participants were identified through purposeful homogenous sampling. Qualitative 
research entails purposefully selecting participants or sites that will best help the 
researcher understand the research problem and answer the research question 
(Creswell 2009:178). In this study, the aim was not to generalise findings to a target 
population but aimed to discover meanings,  explore and explain events as close as 
possible to the people who had experienced the phenomena or culture that is under 
study (Polit & Beck 2012:515).  
 
3.5.1 Sampling procedure 
 
Purposive sampling approach was used. Polit and Beck (2012:517) described 
purposeful sampling as a strategy that allows researchers to select participants that 
most benefitted the study because they had rich data as they experienced the 
phenomena under study. The purposive sampling approach was used because it 
enabled the researcher to purposefully select participants that most benefitted the 
study, with the assistance of a nurse counsellor, who had an established relationship of 
trust with patients receiving treatment at the hospital. However, the researcher still 
emphasised the issue of voluntary participation. 
 
Participants were recruited when they came to the clinic for their monthly reviews. Since 
BRIDH is an initiating site patients who came for review were mainly those coming for 
CD4 cell count check, those referred back to see doctor for any problems such as 
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severe side-effects, on second line therapy, failing to adhere and those who needed 
change of drug regimen.  
 
3.5.2 Ethical issues related to sampling 
 
Although the purposeful sampling approach was used the researcher respected ethical 
issues where the criteria for sampling was still based on the willingness of patients to 
participate in the study and still emphasised that participation was entirely voluntary 
(Polit & Beck 2012:157).  
 
3.5.3 Inclusion and exclusion criteria 
 
Sampling was based on the eligibility criteria of the patient having been on ART for 
more than six months, above 18 years and is willing to participate. 
 
Inclusion criteria 
 
The inclusion criteria was based on recruiting HIV positive patients on ART aged 18 
years and above attending ART clinic at BRIDH with the following characteristics: 
 
• Confirmed HIV positive diagnosis 
• Currently taking ARV treatment 
• Has been taking ARV treatment  for at least six months 
• Able to provide informed consent 
 
Eligible patients with informed consent were recruited and their anonymity maintained. 
 
Exclusion criteria 
 
People with the following characteristics were excluded from participating in the study: 
 
• HIV and AIDS patients not currently on ART 
• Patients below 18 years 
• Patients not consented to participate in the study 
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3.6 DATA COLLECTION 
 
Data collection was conducted at the hospital (BRIDH) between August and September 
2013. 
 
3.6.1 Data collection approach and method 
 
The researcher conducted face-to-face interviews with the participants using a semi-
structured interview guide and at the same time took detailed notes of the conversations 
(Annex 5 and 6). As note taking sometimes disrupts the researchers, and sometimes 
tend to be incomplete and biased by interviewers memory and personal views, the 
researcher decided to audio tape the conversations as well to ensure that interview data 
were participants actual verbatim responses (Polit & Beck 2012:534).  
 
3.6.2 Characteristics of data collection instrument 
 
The data collection tool used was a semi-structured interview guide. The tool was also 
translated from English to vernacular language (Shona) to allow the researcher to 
express clearly the questions to the participants in the language they mostly understood 
(Annex 5 and 6)  Notes were taken and a quality audio tape was used to record the 
conversations. 
 
3.6.3 Data collection process 
 
Data collection was conducted at the hospital and every effort was made to ensure that 
respondents felt comfortable. Patients were recruited when they came to the clinic for 
reviews. Polit and Beck (2012:533) posed the need for qualitative researchers to gain 
and maintain a high level of trust with the participants and “be like them” as this will 
allow them to get rich data. During the data collection period the researcher on a daily 
basis joined the patients as they all first assembled in a hall awaiting reviews and hold 
devotional prayers which were followed by health education sessions from the 
counsellor. The counsellor, who was acquainted with the patients, introduced the 
researcher to the patients while they were still gathered as a group in the hall so as to 
enable the researcher gain trust from the participants. In turn, the researcher was given 
the opportunity to address the patients as a group and explained the purpose of study 
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and asked those who were willing to participate (voluntarily) to see the researcher at a 
private room for more details about the research. 
 
Face to face in-depth interviews were conducted with the participants who volunteered 
to participate. The researcher ensured that the interview process was done according to 
the study protocol which included introductions, explaining purpose of study, what it 
entailed to participate and obtaining written consent before the interviews. The 
interviews captured information on socio-demographic characteristics, knowledge of 
HIV and ART, duration on ART, perceived benefits of ART, adherence facilitators, 
costs, accessibility of ART site, side-effects, disclosure, social and family support, and 
quality of health delivery. Face to face interviews allowed the researcher to adapt the 
questions as necessary and ensured that the questions were properly understood by 
repeating or rephrasing the question. Furthermore, the researcher was able to observe 
the participant facial expression or body language which in turn gave the researcher a 
clearer indication of the participants’ true honest feelings or emotions. However, face to 
face interviews may sometimes be biased as participants tend to give social desirable 
answers and some may feel uneasy about answering personal questions (Joubert & 
Ehrlich 2007:108). 
 
In this study ART adherence was measured by patients self-report of missing doses and 
missing appointments. Participants were asked to recall if they missed a dose or fail to 
adhere to the scheduled dosing time in the last three days, previous week, then 
previous month or any other time when he or she missed doses or appointments. 
Participants were also asked if they recall missing an appointment over the past three 
months or any other time. 
 
Data was collected until saturation occurred. Data saturation occurs when sampling is 
done up to a point at which no information is obtained and redundancy achieved 
(Creswell 2007:64; Polit & Beck 2012:521). In this study, although an estimated sample 
size of 15 participants was given, 20 patients were interviewed as the researcher had to 
collect data until saturation occurred. 
 
Open-ended questions were used as they allowed the participants to express freely 
their experiences of taking ART and at the same time the researcher was able to probe 
participants’ answers. Interviews were carried out in a relaxed atmosphere where 
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participants were able to narrate their stories in their own words. Sometimes in-depth 
interviews may not necessarily follow the sequence of asking questions as they appear 
in the interview guide as each point can be the beginning of a particular discussion 
(Joubert & Ehrlich 2007:320). In this study the researcher noted that the questions were 
not asked in order as they appear in the semi-structured guide as some questions which 
were later on the list were already answered as participants narrated their full stories. 
Data was captured by taking detailed notes of the conversations and audio recording to 
those who consented to audio tape. Participants who had issues or problems and 
needed help were referred back to counsellors.  
 
3.6.4 Ethical issues related to data collection 
 
With studies involving human beings as study participants, the researcher must 
exercise care and ensure that their rights are protected (Polit & Beck 2012:150). The 
researcher respected all the ethical issues pertaining to the study.  
 
3.6.4.1 Study permissions 
 
Permission to conduct the study was initially sought and granted from the Department of 
Health Studies, UNISA Research Ethics Committee (Annex 1). Permission to conduct 
study at the study site (BRIDH) was sought and granted from the Director of Health 
Services of Harare City Health Department after the Institutional Review Board 
scrutinised the proposal and gave their permission as well (Annex 2, 3 and 4). 
Furthermore, permission was also sought and granted from the Medical Research 
Council of Zimbabwe (MRCZ) which is a controlling body that regulates all medical 
research in Zimbabwe (Annex 11 and 12). 
 
3.6.4.2 Informed consent, confidentiality, anonymity and privacy 
 
Informed consent entails that the participants are given adequate information about the 
research, understand it, and can consent or decline participation (Polit & Beck 
2012:157). The researcher was given the opportunity to explain to the entire group the 
purpose of the study, what it entails to participate and emphasised that participation was 
voluntary. The researcher gave details on a one to one basis and explained what it 
entails to participate and the contents of the consent form to those who were willing to 
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participate.  A clear explanation was given to participants about the purpose of the 
study. Anonymity issues were also explained that no names would appear on data 
collected but only codes will be used. Confidentiality issues were also mentioned that no 
one would have access to the information and that the information would not be shared 
with anyone except the supervisors. Participants who consented to participate were 
asked to sign consent forms before the interviews. Also consent was sought from 
participants to audio tape the conversations and they were asked to sign consent forms 
for audio taping. Consent forms were translated to vernacular language (Shona) to 
ensure that the patients fully understood the contents of the consent form and they were 
given copies of the consent forms. Contact details of the researcher and the supervisor 
were disclosed to participants. All the participants interviewed were literate (able to read 
and write) therefore it was easier for them to read, understand the contents of the 
consent forms and to put their signatures (Annex 7, 8, 9 and 10). Participants did not 
incur any financial expenses as they had come for their monthly reviews. 
 
3.6.4.3 Right to withdraw 
 
Participants were also told about their right to withdraw at any time and that it would not 
jeopardise their treatment. However, audio-taping was not done to those who were not 
comfortable with audio tapes.  
 
3.6.4.4 Risks and discomfort 
 
Participants did not encounter any risk. However due to the nature of in-depth 
interviews the researcher had already made arrangements with the counsellor to refer 
those who may have emotional disturbances but fortunately none of them experienced 
any discomfort. 
 
3.7 TRUSTWORTHINESS OF THE STUDY 
 
Creswell (2007:207) states that a qualitative researcher should personally be involved in 
every step of the research process, researcher need to go out and find the “truth” and 
ensure prolonged engagement in the field in order to understand the social reality of the 
participants. The researcher personally went out in the field, adhered to techniques for 
collecting data, was well versed about the character of the data, data analysis and 
reported true findings. 
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3.7.1 Credibility of the study 
 
The researcher created a good rapport with the participants, interacted with the 
participants and had enough time to collect thorough, rich data. Data collection 
instrument was translated to vernacular language (Shona) and this ensured that 
questions were asked in a language that the participants understood. There was no 
language barrier as the researcher was well conversant with the participants’ language. 
Multiple field visits were conducted and data was collected until saturation occurred.  An 
accurate analysis and truthful reporting of findings was maintained by the researcher.   
 
3.7.2 Dependability 
 
Polit and Beck (2012:585) defined dependability as the stability or reliability of data over 
time and conditions. In this study the researcher took detailed field notes and audio 
taped the conversations, then transcribed audio tapes and cross checked with the 
information captured on the field notes. However, interpretation and approach to the 
study may be influenced by the researcher’s past experiences, biases and prejudices 
(Creswell 2007:208). In this study the researcher set aside stories and past 
experiences.   
 
3.7.3 Member checking 
 
The researcher played back the audio tape at the end of each interview to confirm if the 
conversations were captured and also to confirm that the information was what the 
participants wanted to report. 
 
3.7.4 Transferability 
 
Transferability refers to the extent to which findings can be transferred in other settings 
or groups (Polit & Beck 2012:585). The data collected comprised of rich and detailed 
descriptions obtained from the participants and also the findings, interpretations and 
conclusions were supported by data. The detailed descriptions will enable the readers 
to assess whether the findings can be transferred or not and they will also consider the 
characteristics shared by the participants and the study site as well since this was an 
urban setting. However, since study participants were drawn from BRIDH’s catchment 
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areas which were mainly urban suburbs some of the findings may not be transferrable 
to rural settings. 
 
3.8 DATA ANALYSIS 
 
The purpose of data analysis is to organise, provide structure and elicit meaning from 
the data (Polit & Beck 2012:556). The tapes were played several times, then verbatim 
transcribed to text and the information was stored electronically in Microsoft word. 
Information from field notes were cross checked with verbatim responses of the 
participants and also stored electronically. The researcher read through the transcripts 
several times so as to get an understanding of the responses from the participant and to 
search for common themes. Thematic analysis method described in Polit and Beck 
(2012:562) was used to analyse data. The method was the most suitable as it relies on 
the similarity principle which entailed looking for units of information with similar content, 
symbols or meaning and the contrast principle which involved finding out how content or 
symbols differ from  other content or symbol then identified what was distinctive about 
emerging themes or categories (Polit & Beck 2012:562). In contrast to quantitative 
research, qualitative research deals with words rather than numbers where the 
researcher looked for explanations from the person who had experienced the 
phenomena. 
 
DeSantis and Ugarriza in Polit and Beck (2012:562) defined a theme as an abstract that 
entity that brings meaning and identity to a current experience and its variant 
manifestation. By using the thematic analysis the researcher ensured that less bias was 
introduced as themes were produced from the results of the research and were not 
invented by the researcher. The researcher grouped the results by themes. Validation of 
the themes was done to ensure that themes accurately represented the perspective of 
the participants. 
 
3.9 CONCLUSION 
 
Research design, sampling procedures, data collection process and research analysis 
approaches utilised in this study were described. Ethical issues were also discussed.
  
41 
CHAPTER 4 
 
RESEARCH RESULTS AND DISCUSSIONS 
 
 
4.1 INTRODUCTION 
 
This chapter summarises the research findings of the study basing on the participants 
responses from the in-depth interviews conducted by the researcher during the data 
collection period. Twenty (20) participants aged between 28-58 years were interviewed 
and among them were thirteen (13) females and seven (7) males. The participants had 
been taking ARVs for a period range of between 6 months to 9 years. The interviews 
were focussed on answering the following research question: 
 
“What are the various facilitators regarding ART adherence from the patients 
perspective”. 
 
4.2 RESEARCH RESULTS 
 
The study focussed mainly on exploring factors influencing adherence to ART that were 
experienced by the participants and also identified factors within the patient’s treatment, 
socio-cultural and service delivery context. Responses from participants revealed that, 
patients on ART, being the drivers of the programme showed that most facilitators to 
ART adherence revolved around the individual. Findings from Nunes et al (2009:56) 
indicated that patient’s decisions about taking medicines are made within the patient’s 
own frame of reference and make sense within the patients understanding. As the 
researcher explored adherence factors some non-adherence factors also came out from 
the responses.  
 
Basing on the issues that arose from the participants responses the researcher 
identified five themes that influenced adherence to antiretroviral among adult patients 
attending antiretroviral therapy clinic at Beatrice Infectious Disease Hospital (BRIDH). 
The identified themes were knowledge on HIV and AIDS and ART, motivation to live, 
adherence support networks, good service delivery and factors related to medication. 
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The themes were further broken down into sub-themes and sub-themes into categories. 
An overlap of categories that emerged from the themes was also identified. Table 4.1 
gives a summary of themes, categories and sub-categories identified. 
 
Table 4.1:  Summary of themes, categories and sub-categories 
 
Themes Categories Sub-categories 
Theme 1: 
Knowledge on 
HIV/AIDS and ART 
• Health education 
sessions 
• Counselling sessions 
 
• Knowledge on HIV and AIDS 
• Knowledge on ART and ART 
adherence 
• Knowledge on ART side-effects 
Theme 2: 
Motivation to live 
 
• Improved health 
• Innovations to adhering 
to ART treatment 
• Perceived benefits of ART 
• Adhering to appointments date  
• Use of cell phone alarms  
• Carrying extra doses of ARVs  
• Use of meal times  
• Making own treatment plan  
• Adjusting social life to fit into ARV 
treatment  
Theme 3: 
Adherence support 
networks 
• Social support 
• Psychological/emotional   
• Spiritual support  
• Economic support 
• Support from family and relatives  
• Peer support groups 
• Support through counselling  
• Support from church  
• Disclosure, discrimination and self-
stigma 
• Dealing with depression, stress and 
isolation  
• Support with income generating 
projects   
• Support with health-related costs and 
making ARVs affordable   
• Assistance with food  
• Employment  
Theme 4: 
Good service 
delivery  
• Good interpersonal 
relationships 
• Efficient services at 
institution 
• Good relationship with health care 
providers  
• Short waiting time  
• Easy access to ART clinics  
• Comprehensive services offered  
Theme 5: 
Factors related to 
medication 
• Continuous drug supply 
• Pill administration 
• Uninterrupted supply of ARVs  
• Reduction in number of pills  
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4.2.1 Theme 1:  Knowledge on HIV/AIDS and ART 
 
The first theme that emerged was the knowledge of participants on HIV/AIDS and ART. 
Theme 1 was categorised into two categories which entail health education and 
counselling sessions. These played an important role in dissemination of information on 
HIV and AIDS and ART.  
 
The categories were further broken down into three sub-categories and these were 
knowledge on HIV and AIDS, knowledge on ARVs and knowledge on ARV side-effects. 
These will be discussed in detail.  
 
4.2.1.1 Knowledge on HIV/AIDS  
 
Findings from the study revealed that the information participants received empowered 
them to appreciate ART treatment and make positive decisions towards ART 
adherence. Through series of counselling and health education sessions participants 
were equipped with information on the basics of HIV and ART which include mode of 
transmission, the effect of the virus to the immune system, that there is no cure for 
AIDS. From the responses below it showed that most of the participants interviewed 
had adequate knowledge on HIV and AIDS and ART: 
 
“We were taught that there is no cure for HIV, once the virus gets into my 
body it will stay there for life, the only treatment available is ARV drugs”. 
Male, 55 years.  
 
“I know that once someone has HIV the virus will stay in the body for life and 
I should also prevent myself from getting more virus”.  Male, 51years. 
 
“Health educations topics we receive in the hall helped me a lot, they 
reinforce information on HIV and AIDS, ART and we are given chance to 
ask what we do not understand”. Female, 39 years. 
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Discussion 
 
Patient knowledge and information about the disease contributed to adherence. The 
study findings concur with Amico et al (2011:2) which revealed that a good 
understanding of HIV and AIDS was associated with good adherence. Findings also 
concur with Ross, Aung, Campell and Ogumbanjo (2011:2) that one’s   acceptance of 
being HIV positive and the belief that HIV is treated by ART only led to better adherence 
to ART.  
 
4.2.1.2 Knowledge on ART and ART adherence 
 
In-depth knowledge on ARVs assisted patients to make a decision of optimal 
adherence. With respect to information on ARVs, most respondents were quite 
knowledgeable on the names of the ARVs they were taking, how they work, that it was 
a lifelong treatment and were quite conversant about the benefits for adhering and the 
consequences for not adhering. Furthermore, some responses had detailed information 
about how ARVs work and that the ARVs reduce the viral load and the effects of HIV on 
CD4 cell count. Below are some of the participants’ responses: 
 
“ARVs are not a cure, they improve an individual’s quality of life, they also 
prolong life and I know it is a lifelong treatment”. Female, 37-years-old. 
 
“ARVs have improved quality of life, although I am not sick now I know that I 
need to take them for life because they are not a cure”. Female, 32-years-
old. 
 
 “I came for my CD4 count results, and I am happy that my CD4 count has 
gone up. Before I started treatment my CD4 count was150 but because I 
have been taking my ARVs as prescribed my CD4 count is normal”. Male, 
55 years. 
 
“I was not sick but my husband was sick. When I accompanied him here I 
was also tested for HIV, my result was positive and my CD4 count was very 
low, then I was also commenced on ARVs”. Female 39 years. 
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Discussion 
 
Findings from this study concur with Maokisa (2011:35) that continuous education is 
one of the factors that promote adherence. However it has been found that knowledge 
levels only do not translate into action as revealed in Amico et al (2011:5) study that 
information only did not necessarily imply high levels of adherence but also relates to 
ones fund of behavioural skills. 
 
4.2.1.3 Knowledge on ART side-effects 
 
Giving information to patients about the possible side-effects of ART may increase 
adherence levels as the patients will be prepared and know what to do if they 
experience side-effects. If side-effects are not managed well they may interfere with 
adherence to ART. Possible side-effects that may occur when one is taking ARVs were 
discussed with patients during counselling sessions and they were also informed that 
they should come back to see doctor and should not discontinue treatment on their own 
if they encounter side-effects. Among the common side-effects experienced by study 
participants were vomiting, rash, abscesses, numbness in lower legs and severe 
reaction to sulphur. Responses from participants indicated that side-effects experienced 
by some participants had no interference with their ARV treatment as they were 
empowered with enough information on what to do and they also had the knowledge 
that some less severe side-effects would disappear over time. 
 
Timely management of the side-effects was also identified as a factor that facilitated 
adherence.  At the hospital there is always a doctor in attendance who quickly attends 
to patients who have encountered problems with side-effects. Below are narrations from 
participants on how they handled side-effects: 
 
“Initially I had rash all over the body but I didn’t stop my ARVs. We were told 
that we should come back and see a doctor if there are problems and not to 
stop treatment on our own, so I came back to see a doctor”. Female, 39-
years-old. 
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”When I started ARVs I had nausea, vomiting, felt sick, it was bad, but I did 
not stop my pills. I came back to the clinic and had treatment for the side-
effects”. Female, 32-years-old. 
 
“I had a severe reaction due to Cotrimaxazole (Allergic to Sulphur), I came 
back to the clinic and they stopped the Cotrimoxazole”. Female, 39-years-
old.  
 
Discussion 
 
Side-effects can make one not to adhere to treatment as some patients discontinued 
ARV treatment when they experienced severe side-effects (Maokisa 2011:9). 
Sometimes patients may not have a clear understanding of side-effects and tend to 
associate any illness that occurs to them whilst on treatment side-effects as side-effects 
of ARVs. Do (2011:139) also reported side-effects from antiretroviral medication as one 
of the most common factors that contributed to non-adherence to ART. Contrary, 
findings from this study revealed that some individuals did not discontinue ARV 
treatment when they experience severe side-effects as they had adequate information 
on what to do if they experience side-effects. 
 
4.2.2 Theme 2:  Motivation to live 
 
The second theme identified was motivation to live as a facilitator to ART adherence. 
Two categories were identified in theme 2 and these were improved health and 
innovations made by the patients themselves to adhere to ART treatment. 
 
Sub categories which entail perceived benefits of ART, adhering to appointment dates, 
use of cell phone alarms, carrying extra doses of ARVs, use of meal times, making own 
treatment plan and adjusting social life to fit into ARV treatment were identified as 
facilitators to ARV adherence. From the participants responses it showed that they 
valued ARVs as they had tasted the benefits of ARVs therefore gave priority to ART 
treatment and ensured that they kept appointment dates and adhered to scheduled 
treatment time. Adhering to scheduled times was noted as a challenge to most 
participants. As a way to addressing the challenge study participants designed their own 
convenient times for taking their medication. Use of reminders, making own treatment 
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plan, adjusting social life to fit into ARV treatment, use of meal times and carrying the 
pills when one had a journey were some of innovations designed by patients to make 
them adhere to dosing times. 
 
4.2.2.1 Perceived benefits of ART 
 
The respondents were asked to explain the benefits they have realised since they 
started the antiretroviral treatment.  Findings from the study indicated that participants 
who had experienced and enjoyed the benefits of ART had good adherence as 
indicated by some responses below:  
 
“ARVs have improved my health, I was very sick in 2007, had pleural 
effusion and was diagnosed TB, put on TB treatment although no AFBs 
were seen in the sputum. There was no change until I was tested for HIV 
and put on ARVs”. Male, 55 years. 
 
“ARVs are very helpful. I was very sick, was treated for TB but there was no 
improvement, then was tested for HIV then was commenced on ARVs.  
Since then my health has improved. I came here (at this ART clinic) in a 
wheelbarrow, I could not walk, but after taking ARVs I have noticed a 
speedy recovery. I had lost weight, my weight was 65kgs, then I reduced to 
46 kgs, but  look at me now I managed to gain 11 kgs in a few months after 
commencement of ARV treatment”. Male, 40 years. 
 
“I was very sick, I was very thin, I could not walk or do even household 
chores, but look at me now I now fit and am now back at work”. Female, 47 
years. 
 
“No, I never miss appointments, because I know the importance of ARVs, 
and I am well informed about ARVs, I strive to live and I don’t want any 
relapses”. Male, 28 years. 
 
Participant 19 “I have really benefitted from ARVs, I had frequent OIs, had 
chronic diarrhoea, my weight reduced from 80 kgs to 63 kgs, I had Typhoid, 
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and so many diseases which I could not understand. But since I started 
ARVs these have since stopped and I have gained weight again”. 
 
“ARVs are very helpful, but they delayed commencing me on ARVs. I had 
an HIV test in 2011 but they put me on Cotrimoxazole only, then later on 
when my CD4 count was low that is when they commenced me on ARVs”. 
Male, 40 years. 
 
Discussion 
 
These findings concur with Mbirimtengerenji et al (2013) that patients on ART who 
noted improvement of their general health status were motivated to adhere to 
antiretroviral treatment, they keep all the appointments and did not miss a dose as they 
could see that ART made a difference in their quality of life. The same results were also 
reported by Ayalu et al (2011) who reported that a change in health status of a client 
had influence on adherence to ART and if there is improvement in health the influence 
is positive and a negative influence if there is deterioration in health status.  
 
4.2.2.2 Adhering to appointments date 
 
The consequence of not missing appointments was well understood by study 
participants as a result of intensive counselling sessions received prior to ART 
enrolment. At the ART clinic, once a patient has been considered eligible for treatment 
and commenced on ART, one is required to attend monthly reviews where adherence 
level is monitored, patient’s health status assessed and given monthly supply of 
antiretroviral drugs. From participants responses below it showed keeping appointment 
dates enabled them to adhere to their treatment as they would not run short of supply of 
medication: 
 
“I never missed appointments because I value the pills. They helped me a 
lot, I don’t suffer from any illnesses. ARVs have kept me alive”. Female, 38-
years-old. 
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“I never miss an appointment because I want to live. If I don’t have money I 
borrow money to come here, just like now I have borrowed money to come 
here for my review”. Female, 38 years. 
 
“I missed my appointment last month when I went to my rural home and 
failed to come back for my appointment because my mother was very sick 
and later on she died, however because counsellor had told us that we can 
go to nearest clinic I went to the nearest health centre where they supplied 
me with a week supply to cater for the extra days I was home therefore I did 
not default my treatment”. Male, 51 years. 
 
“No I never missed an appointment, I want to live, I also do not want to miss 
the health education sessions so I always meet my appointments”. Male, 40 
years. 
 
“I value the issue of keeping my appointment dates, for instances when 
there was a death in our family, I first came here to collect my pills before I 
proceeded to our rural home for burial, and the staff is good also they 
attended to me first”. Male, 43 years. 
 
“No I never miss an appointment because I value this treatment, it has 
improved my quality of life, my children are still young, I want to see them 
growing”. Female, 34 years. 
 
4.2.2.3 Use of cell phone alarms 
 
Forgetfulness was found as one of the main factors that caused one not to adhere to 
treatment therefore participants relied mostly on cell phone alarms to help them to 
maintain their adherence. Use of cell phone alarms was found to be a very convenient 
reminder as it is portable and served two purposes of communication and to alarm the 
patient on dosing time. This is indicated from responses below: 
 
“I always set my phone alarm to remind me when it is time to take my pills 
and this enables me to adhere to the prescribed scheduled times”. Female, 
32 years. 
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“I always take my pills as prescribed, I use phone alarm to remind me and 
my family remind me as well”. Male 44 years. 
 
“I never missed a dose, I set my phone alarm. I always carry a few tablets 
with me if I anticipate delay so that I take my pills on the prescribed time”. 
Male 40 years. 
 
Discussion 
 
Use of cell phone alarms as reminders has also been reported by Marukutira (2012:70) 
as the most convenient reminders as nowadays most people own cell phone alarms for 
communication purposes.  Marukutira (2012) also identified forgetfulness as a major 
contributing factor to non-adherence, and patients on ART used reminders such as 
mobile phone, text messages, cell phones and alarm clocks or watches to improve 
adherence. This is also supported by Maokisa (2011:23) whose study showed that most 
patients used clock/cell phone alarms as reminders to ARVs. 
 
However, some participants were not comfortable with alarms when they were at public 
places or a social gathering as they felt that it could be an embarrassment when it 
alarms then everyone would be aware of the persons HIV status as indicated by one 
participant: 
 
“I switch off my cell phone alarm whenever I go to a social gathering 
because it alerts everyone and this embarrasses me when I try to explain 
why I set the alarm”. Female 34-years-old. 
 
4.2.2.4 Carrying extra doses of ARVs 
 
Carrying extra doses of ARVs enabled patients to adhere to scheduled times and 
consequently improved adherence levels to ART. As participants noted that change in 
their daily routine affected adherence to treatment they developed a strategy of moving 
with extra doses of ARVs wherever they go as stated from the responses below: 
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“I carry some of my pills in my handbag so that whenever it is the time to 
take my pills and am away from home I will not skip my dose since most of 
the time I go out with my handbag”. Female, 34-years-old. 
 
“I always carry a few tablets with me in my handbag, sometimes I finish work 
late or I fail to get transport early, then I take my tablets even at the bus 
stop”. Female, 38-years-old. 
 
“I missed my doses last week when I travelled but now I pack a few pills and 
go with them wherever I go”. Female, 44-years-old. 
 
“I missed a dose in July (a month ago) when I attended an emergence, I 
took my relative who was sick to hospital and spent the night there so I 
missed my dose. But now I carry a few pills with me to cater for those 
unforeseen emergencies”. Female, 47-years-old. 
 
Discussion 
 
ART adherence requires one to adhere to the scheduled dosing times but in some 
instances this might not be possible. Findings concur with Do (2011:149) that factors 
such as being too busy, special events changing daily schedule, travel and oversleeping 
among others as factors that prevented PLHIV from taking their ARVs. This is also 
supported by Jean-Baptiste (2008:16) who cited most common reasons for non-
adherence as patients forgetting to take medicine, occupied by other things and client 
not at home during the scheduled time. 
 
4.2.2.5 Use of meal times 
 
Use of meal times was another factor identified that enabled the participants to adhere 
to the scheduled dosing times as indicated below: 
 
“My ARVs are part of my daily meals-breakfast and dinner, I follow my meal 
time, 8 am and 8 pm and this helps me not to miss my dose”. Female, 39-
years-old. 
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“I take my pills together with my meals, ARVs are part of the meal”. Female, 
34-years-old. 
 
4.2.2.6 Making own treatment plan 
 
Change of daily routine sometimes contributed to non-adherence therefore in an effort 
to counter the problem participants designed their own treatment plan to suit the 
scheduled times that was often affected by change of daily routine. This was described 
from participants’ responses below: 
 
“I made my treatment plan, I changed it to suit my shift work hours when I 
am on night duty and day duty. However, I was guided by counsellor that 
morning dose should be not later than 9am so as to accommodate the 
evening dose before I go to sleep”.  Male, 28-years-old. 
 
“Sometimes I forgot to take the doses during the prescribed times when I am 
at work therefore I worked out my own treatment plan that is convenient to 
me. I used to take the pills at 8am and 8 pm but have now shifted to 7am 
and 7 pm to suit my work hours, and since then I have not missed doses”. 
Male, 40-years-old. 
 
Discussion 
 
Responses from participants showed commitment and innovative ideas from the 
patients themselves as they strive to maintain high adherence levels to their treatment. 
This concurs with Skovdal et al (2011b:301) that adoption of a patient centred approach 
which entailed involvement of the patient to make own treatment plan promoted 
adherence levels.  Similar recommendations were made by  that ART requires much 
commitment, involvement in decisions pertaining to their treatment and fully 
participation from the patient.  
 
4.2.2.7 Adjusting social life to fit into ARV treatment 
 
Alcohol abuse is known to interfere with ARV treatment as one may forget to take the 
medication or take it wrongly. Changing life style and fitting ART doses into the daily 
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routine was found to be a contributory factor to ART adherence. Furthermore the study 
revealed that adherence to ARV treatment depended on ones willingness to adjust and 
manage own illness. Some participants reported that they stopped taking alcohol 
completely and some only managed to reduce the consumption and adjusted their 
social life to fit into ART treatment as indicated from responses below: 
 
“I drink alcohol, I was advised to stop, I have not stopped completely, but I 
have reduced the consumption. I am still trying to stop drinking alcohol 
because I know that this may affect my treatment”. Male, 43-years-old. 
“I used to smoke and drink but I stopped when I was commenced on ARVs 
as I realised that I would not be able to take my ARVs properly if I continued 
to drink alcohol”. Male, 45-years-old. 
 
Discussion 
 
Findings concur with Chizanga (2010:155), Chesney (2012:1), Do (2011:132), Shumba 
et al (2013:3) and Maokisa (2011:7) that  patients on ART who took alcohol had 
difficulties in adhering to antiretroviral treatment as they sometimes failed to take their 
medication at the prescribed dosing times or sometimes omitted the treatment. Although 
directly observed therapy (DOT) has been seen to be effective in provision of ART to 
drug active users, the strategy was found to be not sustainable to ARV users as it is a 
long life treatment (HSS Panel on Antiretroviral Guidelines for Adults & Adolescents 
2012:182). However, the issue of giving social desirable answers might have been 
possible as participants reported that they stopped taking alcohol.In an effort to reduce 
social desirability Do, Dunne, Kato, Pham and Nguyen (2013) recommended the audio 
computer assisted self-interview (ACASI) which is a computer method for administering 
questionnaires. 
 
4.2.3 Theme 3:  Adherence support networks 
 
The presence of adherence support networks was the third theme identified as a 
facilitator to ART adherence.  Four categories were identified and these were grouped 
as social support, psychological/emotional and spiritual support and economic support. 
The study revealed that a holistic support offered to patients on ART enabled patients to 
adhere to ART.  
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From participants responses it showed that support from family members, peers, church 
and support through counselling sessions enabled them to adhere to their ARV 
treatment. Some of the other facilitators identified were support given to patients after 
disclosure, non-discrimination, dealing with depression, stress and non isolation. 
Support with income generating projects and employment, assistance with food, making 
ARVs affordable and support with other related costs facilitated adherence to ARV 
treatment. These sub-categories will be discussed in detail. 
 
4.2.3.1 Support from family, neighbours and relatives 
 
Social support networks entailed support from family, neighbours and relatives and peer 
support groups. 
 
Support from family members, relatives and friends plays an important role in 
supporting PLWHA to maintain ART adherence. It was observed that most participants 
were accompanied by their relatives when they came for their monthly reviews. From 
participants responses it was noted that good support system from relatives, 
neighbours, family and friends facilitated their adherence to ART as indicated in the 
responses below: 
 
“My husband is here with me now, he is very supportive. He always 
accompanies me when I come for my reviews and reminds me to take my 
pills”. Female, 37-years-old. 
 
“I disclosed to my wife, she is also HIV positive and on ARVs as well, she is 
very supportive and we remind each other”. Male 51-years-old. 
 
“My brother is very supportive, first time when I came here in a wheelbarrow 
he was the one who accompanied me and stayed with me at my house until 
I was better. He sometimes gives me money to buy extra food and sends 
me a text message to remind me to take my pills”. Male, 40-years-old. 
 
 “My husband died last year in June. My children always remind me, they 
even bring the tablets and a cup of water to make sure that I have taken my 
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pills. My neighbour also checks on me almost every day and sometimes 
help me with house hold chores when I am not well”. Female, 34-years-old. 
 
4.2.3.2 Peer support groups 
 
Peer support groups, interaction of patients and testimonies were identified as some of 
the facilitators to patients’ adherence to ART. As patients came for their reviews they 
first assembled in a hall which seemed to be like a temporary support group where they 
have prayers and health education talks. In the hall, the patients had an opportunity to 
interact and had open discussions about their HIV positive status, how they benefitted 
from ARV treatment, challenges encountered in ARV treatment and also shared their 
emotional challenges. Furthermore, through testimonies offered in the hall patients had 
the opportunity to share their experiences and assisted each other to find solutions for 
challenges faced in maintaining ART adherence: 
 
“When we meet in the hall it seems to be a temporary support group to us 
because we interact and share our experiences and we hear from others 
how they have overcome challenges faced in ART treatment. Also I 
appreciate devotional sessions because they are part of counselling and 
they also address my spiritual needs as well”. Female, 34-years-old. 
 
”I appreciate the morning peer interactions, as it is like a support group, we 
support each other and learn from others through their testimonies how they 
have managed to adhere to ARV treatment for so many years. The 
testimonies also help to reduce stigma and I could see that I was not alone”. 
Male, 28-years-old. 
 
Discussion 
 
Findings concur with Marukira (2012:50) where most adolescents who had support from 
family, friends and the society reported high levels of adherence. This is also supported 
by Zuurmond (2008:4) that availability of a strong supportive family and support group 
meetings for people living with HIV and AIDS increased adherence to ART. 
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4.2.3.3 Support through counselling  
 
Study findings revealed that series of counselling sessions given to patients and 
caregivers assisted them to make informed decisions about ART as they were 
empowered with information. The counselling sessions also provided emotional and 
psychological support to patients who needed it.  Initially all  patients undergo a 
minimum of three counselling sessions before commencement of ARVs, then 
adherence counselling session offered again to those who fail to adhere. Some 
caregivers who had accompanied the patients were also engaged in the counselling 
sessions as among the patients there were some who were too ill to comprehend 
treatment instructions. Responses below revealed how counselling sessions assisted 
participants to adhere to ART:  
 
“The adherence counselling sessions helped me not to miss my 
appointments and my doses as well”. Female, 44-years-old. 
 
“Counselling sessions helped me more than the pills, I managed to accept 
my status and to adhere to my treatment. I had so many counselling 
sessions and they were very helpful. Initially I failed to adhere to my 
treatment because I was stigmatised by relatives but because I had series 
of counselling sessions it really helped me to cope with the stressful 
situation”. Female, 35-years-old. 
 
“Counselling sessions have really helped me to reduce my stress and to 
understand the importance of adhering to my treatment”. Female, 38-years-
old. 
 
“I got the initial three adherence counselling sessions and when I missed my 
appointment, then I was referred back to counsellors for adherence 
counselling”. Female, 47-years-old. 
 
“I never miss appointments, because I know the benefits of ARVs, and I am 
well informed about ARVs, I want to stay alive and I don’t want any 
relapses”. Female, aged 35 years. 
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Discussion 
 
Counselling played a key role in disseminating information on HIV and AIDS and ARVs. 
Responses from participants concurs with what was found by Mendelsohn (2012:82) 
who reported that quality counselling from trained counsellors is a key requirement for 
successful ARV adherence. Hansanna, Sanchaisuriya, Durham and Sycharean 
(2013:8) also identified counselling and education as effective interventions towards 
ART adherence.  
 
4.2.3.4 Support from church 
 
One’s religious beliefs can impact negatively or positively on ART adherence. Findings 
from this study revealed that those who disclosed to church members received support 
through prayers (spiritual support) and some were assisted with material things from the 
church as indicated from responses below: 
 
“I disclosed to my fellow church members, and we have a peer support group where I 
am also involved in counselling my peers. When is fasting period we have agreed that 
we will fast for only half a day”. Female, 37-years-old. 
 
“Some churches now teach about HIV and AIDs and they even support church 
members on ART with their material needs”. Female, 44-years-old. 
 
Discussion 
 
Contrary, findings from this study also revealed that sometimes patients are so 
desperate that as they searched for alternative ways of curing the virus they were 
advised by their pastors to stop ARVs completely and believe that the prayers from the 
church have cured the virus and continuing with medication implies that they lack faith 
in God. However, the same patients, after noticing relapses in opportunistic infections 
they came back for recommencement of the ARV treatment as reflected in responses 
below: 
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“I have been taking ARVs religiously for two years and I never missed a 
dose but then when I joined one faith healing churches the pastor asked me 
to stop ARVs and believe in God that I have been healed.  Three months 
after I had stopped ARVs I became very sick. I came back here, I had 
sessions of adherence counselling from the counsellor and I was 
recommenced on treatment. And now I am on second line therapy, I gave 
my testimony to others that we must not stop ARVs”. Male, 45-years-old. 
 
“My church discourages us from taking pills, so I did not disclose to them 
that I take ARVs, but because I also have faith in the holy water they give 
me I now use the water to take my  ARVs”. Male, 55-years-old.  
 
” Some churches against ARVs, I wish if our counsellors can go to these 
churches and educated these pastors on importance of ARVs”. Male, 45-
years-old. 
 
Discussion 
 
One of the main challenges noted in this study was that despite good counselling 
sessions and patients showing commitment to ART it was discouraging to see that 
some discontinued treatment after negative advice by their pastors. This could be as a 
result of stress experience by PLWHA which occur from the day they are told they are 
HIV positive and will be struggling to live with the stress. As a coping mechanism the 
stress disappeared when one is told that that the virus has been cured when in actual 
fact the virus will continue to attack CD4 cells if one stops treatment.  
 
It was noted that religious beliefs reversed the gains that had been achieved towards 
ART adherence at BRIDH. Findings concur with Maokisa (2011:32) that religious beliefs 
had an influence in ART adherence hence need to address the religious belief and 
practices during counselling sessions. A study by Mbirimtengerenji et al (2013:20-21) 
also revealed that most Christians adhered to ART than other religions whilst non-
adherence was also noted in some strong religious believers who believed that God had 
supernatural powers and heals HIV and AIDS and   discontinued treatment. 
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4.2.3.5 Disclosure, discrimination and self-stigma 
 
Disclosure of one’s HIV positive status is a significant factor towards ART adherence as 
it can have either a negative or positive impact towards ART adherence. Patients who 
disclosed their HIV positive status were able to get the necessary support required to 
enable them to adhere to ARV treatment. However, for some the decision to disclose 
was not an easy task as they thought they may end up being stigmatised and 
discriminated. Also the idea of decentralising ART clinics and transferring patients to 
local clinics was not welcomed by some participants as they would meet neighbours in 
the same queue. However, as a way of dealing with this self-stigma at this hospital 
patients were given options of getting their monthly refills of ARVs at the clinic of their 
own choice.  
 
The following were participants’ responses: 
 
“I meet neighbours at the local clinic where I am taking my ARVs, so they 
will all know that I am HIV positive. But thanks to counsellors they gave me 
an option to go to any health facility that I was comfortable to go for my 
monthly reviews”. Male, 28-years-old.  
 
“I did not disclose to employer and workmates for fear of being stigmatised”. 
Female, 34-years-old. 
 
“In 2004 when I disclosed my HIV status to my relatives they stigmatised 
me, my sister did not even want to share a bed with me but now they have 
changed and they are very supportive”. Female, 35-years-old. 
 
“I missed my appointment because I was at work, I am a house maid, 
initially I did not disclose to my employer for fear of losing my employment 
but later on when I disclosed I noticed that my employer is very supportive 
and I have not missed my appointment since then. My employer even allows 
me to come to my parent’s house a day before the appointment date for 
easy access”. Female, 38-years-old. 
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Discussion 
 
Similar results were also found in a study done in Nigeria which revealed that good 
adherence was associated with disclosure of HIV status as they engaged the 
community in HIV and AIDS care thereby encouraging disclosure and reduced stigma 
(Charurat et al 2010:5; Ross et al 2011:3). This is also supported by (Skovdal et al 
2011:1; Do 2011:1). that ART adherence can be optimised in the contexts where there 
was openness and acceptance of one’s HIV positive status  Findings also concur with 
Marukutira (2012:66) that most participants who did not disclose their HIV positive 
status due to fear of being stigmatised failed to adhere to treatment.  Nyambura 
(2009:55) study revealed that some women failed to disclose their HIV positive status 
and that they were taking ARVs as they feared being victimised by their husbands  
 
However, the issues of self-stigma still remains a problem in some patients as they are 
still not comfortable in revealing their HIV positive status to  their neighbours and 
employers. Similar results reported by Hansana et al (2013:8) where self-stigma 
resulted in some patients failing to take their medicines in the presence of other people. 
 
4.2.3.6 Dealing with depression, stress and isolation 
 
Dealing with emotional abuse and other social problems that may lead to depression 
was seen to be a strong facilitator for adherence. Being HIV positive and on ART 
sometimes precipitates stress and failure to cope with the emotional difficulties may 
lead to depression and consequently affect ones adherence to ART. Responses from 
participants revealed that those who were isolated, facing abusive situations and 
depressed sometimes failed to adhere to the required treatment prescriptions as they 
were not getting the required support to adhere to ARV treatment: 
 
“I stay alone at my home, my children have their own homes and families 
and only come to take me when I am very sick, but when I am well I will be 
always alone at home. I will feel lonely and depressed therefore I sometimes 
forget to take my pills. And there is no one to remind me”. Female, 51-years-
old. 
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“I frequently miss doses, yesterday I forgot to take my dose in the morning 
because of family problems that are stressing me, my husband deserted me 
and I got depressed”. Female, 34-years-old. 
 
 “Last week I missed my evening dose, my husband is very abusive, and 
even his relatives stigmatise me and they accuse me of bringing HIV in the 
family. This really disturbs me from taking my ARVs regularly. I missed my 
two appointments since I started the treatment a year ago because I failed 
to get bus fare or even the $1 to pay for the clinic card. My husband has 
money but he is not supporting me. (After a pause)- Who can assist me to 
stop this abuse from my husband and my in-laws because this is disturbing 
my treatment?”. Female, 32-years-old. 
 
Discussion 
 
From the above responses it shows that there is still a gap in addressing psycho-
emotional problems that influences adherence to ART. The findings concur with Jean-
Baptiste (2008:17-18) that minimal support and depression were some of the identified 
psychological factors that contributed to non-adherence. A similar study conducted in 
Viet Nam also revealed that heavy alcohol use, low social connectedness and 
depressive symptoms were associated with suboptimal adherence to ART (Do et al 
2013:5). Skovdal et al (2011:3) had similar findings where some men were not 
supportive as they did not want to be associated with HIV, as they perceived HIV and 
AIDS as a threat to their masculinity and illness would belittle their sense of manhood. 
 
4.2.3.7 Support with income generating projects 
 
Poverty can affect ones adherence to ARV treatment. Participant mentioned that if they 
are empowered through assistance with income generating projects, they would be 
economically empowered and be able to earn a living for them and sponsor themselves 
on all health-related costs. 
 
“Being HIV positive does not mean that I cannot do things for myself, if I 
am assisted with working capital I can start a chicken project and help 
myself with food and other necessary items”. Female, age 51-years-old. 
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“I am not employed, if I can be assisted with money to start a project, I will 
be able to generate money for food and to cover all my treatment costs”. 
Female, 39-years-old. 
 
4.2.3.8 Support with health-related costs and making ARVs affordable 
 
Making affordable treatment costs facilitate adherence as indicated by most patients. 
ARVs are supplied free of charge at BRIDH but there are some health-related costs 
such as paying $1.00 for the treatment card. The payment is valid for one week 
therefore if a patient comes more than once a week the patient will still use the same 
card without extra payments. Although the clinic fee was affordable to some patients 
there were a few who indicated that they would like to be assisted with the health-
related costs to facilitate their adherence. Responses below indicated that assisting 
patients with health-related costs improves adherence levels.  
 
“Last month I did not have money to pay for the card so I failed to come for 
my review on the scheduled date. I was referred for adherence counselling 
and the counsellor referred me to social welfare where I got a free treatment 
order so I am exempted from paying the clinic fees”. Female, 37-years-old. 
 
“Although I stay very near the clinic, and my home is a walking distance 
from here, I missed my appointment because I could not afford to pay $1 for 
the card. But now social worker assisted me to get a free treatment order”. 
Female, 51-years-old. 
 
“We get ARVs free but sometimes we are asked to buy Cotrimoxazole when 
it is out of stock here, that is when it becomes expensive for us”.  Female, 
39-years-old. 
 
“Cost is reasonable although I buy one of the ARVs (second line therapy 
drug) that is always out of stock here and it costs between $15-$23 a month 
to include Cotrimoxazole. I always make that budget a priority because I 
have realised the benefits of ARVs”. Female, 36-years-old. 
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”Cost is affordable, $1 is affordable, we are given ARVs free,  just like BP 
tablets you look for money to buy Nifedipine, and the $1 is affordable I can 
even afford to help someone without money to pay for the clinic fees, since 
it is only $1”, Male, 55-years-old. 
 
”Cost is not affordable $1 for treatment and another $1 for travel costs 
where do I get the money from, I am not working and my relatives also do 
not have money even if they wanted to support me. My husband deserted 
me and I am striving to survive”. Female, 34-years-old. 
 
Discussion 
 
Study findings concur with Bemelmans et al (2010:6), Maokisa (2011:32) that making 
cost of ARVs affordable and provision of other ART treatment related costs contributed 
to adherence.  
 
4.2.3.9 Assistance with food 
 
Availability of food promotes adherence. The hospital is attached to a non-governmental 
organisation (NGO) that provided food to some patients on ART. However the food 
ration is given only to undernourished patients and also once the patients regains their 
weight the food ration is discontinued. Responses from participants clearly indicated 
that it was difficult for them to secure enough food and needed to be assisted with food 
as indicated below: 
 
“The pills require one to eat but securing enough food is a problem. Here 
they give food to malnourished people only, if possible can we have more 
food donors so that we can all benefit from the food ration”. Male, 51-
years-old. 
 
“There is an NGO that gives us food, it is helping me a lot but the problem 
is  if I gain weight they will discontinue the food handouts, then because I 
cannot afford food, it becomes a problem again because I will lose weight 
again”. Female, 37-years-old. 
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Findings also revealed that integration of the nutrition programme and ART programme 
promoted adherence as patients would not miss their appointment dates as they also 
want to collect their monthly food ration. Study findings concur with Campbella et al 
(2012:129) that poor nutrition remained a barrier to ART adherence and still need to be 
addressed. 
 
4.2.3.10 Employment  
 
The study revealed that participants who are self-employed had no problems in keeping 
appointments than those who are formally employed. Those who were formally 
employed faced challenges in meeting the review dates as they wanted to minimise the 
frequency of absenteeism at work, hence were suggesting a supply of up to 3 months. 
Patients are given monthly reviews and sometimes only a maximum of up to 2 months 
drug supply so as to constantly monitor adherence. It was also noted that patients who 
did not disclose their HIV status to their employer found it very difficult to ask for time off 
from work to go for their monthly reviews. Below were some of the participants’ 
responses: 
 
“I have never missed my appointments. I do a self-job therefore I manage 
my own time. I have no hustles in trying to get permission from employer.” 
Male, 44-years-old. 
 
“It is difficult for me to ask for permission from my employer every month to 
come for the reviews, since I did not disclose him he would become 
suspicious now because I excuse myself from work every month and almost 
same dates. If possible can we have three months’ supply”. Female, 34-
years-old. 
 
Discussion 
 
Study findings concur with Mbirimtengerenji et al (2013:21) that patients who were self-
employed or had their own businesses adhered better than those who are formally 
employed as they had no hustles in trying to obtain permission from their employers. 
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4.2.4 Theme 4: Good service delivery 
 
The fourth theme that emerged was good service delivery offered by the health workers 
at BRIDH.  Theme 4 was further categorised into two categories and these entail good 
interpersonal relationship between hospital staff and patients and efficient service 
delivery at the institution.  
 
Good relationship with health care providers, short waiting time, easy access to ART 
clinics, decentralisation of ART clinics and availability of comprehensive services 
offered at the hospital were some of the facilitators to ART adherence.  
 
4.2.4.1 Good relationship with health care providers 
 
A good interpersonal relationship between patients and health care providers was found 
to be a strong facilitator to ART adherence. Study participants reported that good 
adequate attention and the cordial relationship they had with the hospital staff boosted 
their morale and were motivated to come for their appointments on the scheduled dates. 
Most of the respondents said that they felt easy to have an open discussion with health 
staff at BRIDH and they also have trust in the health workers. Excerpts of the views of 
the respondents are recorded below: 
 
“The staff here is very friendly, they explain well and direct you to various 
departments in a friendly manner. The problem is at the clinics where they 
transfer us, there is poor service, if it was possible I would prefer to come 
here for my reviews”. Female, 35-years-old. 
 
“I wish I can continue taking my pills at this hospital. Counsellors are very 
good, they treat us with respect and all the staff at this hospital is very 
supportive. They give comprehensive information about all what you need to 
know about ARV treatment”. Female, 37-years-old. 
 
“All the hospital staff is courteous and they listen to us and are 
accommodative. I came late but they served me in a friendly manner. The 
  
66 
problem is at the local clinics where they refer us sometimes I feel like 
defaulting”. Male, 40-years-old. 
 
“There is good reception from all the hospital staff. The other name of this 
hospital Nazareth, which is a true reflection of Nazareth where Jesus healed 
sick people as we are also treated well here”. Female, 47-years-old. 
 
”Counsellors are very good, supportive and very encouraging, if possible 
can the clinic staff be attached to this hospital and be taught about good 
counselling. I even suggest that the salary for all the workers here be 
increased. Health education sessions are very helpful and they allow us ask 
questions freely where we do not understand”. Male, 45-years-old. 
 
Discussion 
 
Similar findings were found in a study by Chizanga (2010:164), Do et al (2013:5), Ross 
et al (2011:4) that friendly and trusting relationship between patients and health care 
providers enabled patients to cope with their illnesses and also it encouraged patients to 
adhere to ARV treatment. Findings also concur with Campell et al (2011:5) that a 
friendly atmosphere displayed by nurses which entailed greeting, listening to patients 
problems and addressing patient’s religious beliefs, were some of factors that facilitated 
adherence to ART. 
 
4.2.4.2 Short waiting time 
 
Findings from this study indicated that service delivery was good as patients were 
served within a reasonable time. If patients are attendant early they always keep their 
appointments as long waiting hours sometimes frustrates patient thereby forcing them 
to miss their appointments. Below are participant’s responses: 
 
“At this hospital there are no problems, the problems are at these periphery 
clinics where there is poor service, we are served late and we queue as 
early as 5 am. There is slow service at the clinic such that I sometimes think 
of defaulting”. Male, 45-years-old. 
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“There is good filling system which makes it easy to retrieve our files, we just 
write the file number and within no time our files are retrieved.  There is 
enough staff, all the departments are covered and the service is quick”. 
Male, 40-years-old. 
 
Discussion 
 
Patients are less likely to miss appointments if they are attended to within a reasonable 
time. Maokisa (2011:30) study revealed that patients who experienced long waiting 
hours were discouraged from going to the clinics for their monthly reviews and refill. 
This is also supported by Campbell et al (2011:5) that patients experienced stress when 
they waited for long hours.  
 
4.2.4.3 Easy access to ART clinics 
 
Easy access to ART centres and affordable transport costs promotes adherence. ART 
centres were decentralised to enable patients to easily get their monthly refills from their 
local ART clinics without incurring any travel costs. Findings from this study indicated 
that participants had no problems in accessing the ART clinic.  Being an urban area the 
participants had easy access to public commuter buses at an affordable cost and all 
were coming from within a radius of 10 kilometres. 
 
“This hospital is not far from my home, it is very accessible, only 5 km from 
my home, and now they transferred me to my local clinic which is a walking 
distance”. Female, 51-years-old. 
 
“There are no problems with transport, its urban area, the cost is affordable, 
only $0.50 one way, then $1 for the card. The only problem is how to get 
food”. Female, 47-years-old. 
 
Discussion 
 
Availability of transport and transport costs were found not to be an issue as the ART 
clinic was easily accessible. Patients who had easy access to ART clinics were more 
adherent than those who spent long hours travelling to treatment facilities (Do 
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2011:132; Charurat et al 2010:5; Shumba et al 2013:4). A study done in Zambia had 
similar findings where distance to ART services and travel expenses were barriers to 
optimal adherence to ART (Nozaki et al 2011:6). 
 
4.2.4.4 Comprehensive services offered 
 
The hospital offers various services required by patients on ART therefore they 
preferred to get their refills at the hospital. The services include testing and counselling, 
ART adherence counselling, CD4 cell count check, social welfare, food facility, 
pharmacy and a doctor who is always in attendance. Study participants indicated that a 
one stop shop where all services are provided at one place promotes adherence: 
 
“I prefer this hospital because it is one stop shop; you get counsellors, 
doctors, pills, CD4 count tested at the same place and this encourages me 
to take my medication”. Male, 55-years-old.  
 
“This hospital is a one stop shop, all the services are available inside this 
gate, we get all the services here, starting from HIV test, counselling, CD4 
count test, review by doctor, and drug refill”. Female, 34-years-old. 
 
Study findings indicated good service delivery which was appreciated by most 
participants as they kept their appointment dates thereby increasing their adherence 
levels. The stress for waiting for long hours waiting for other services was also found to 
be worsened by failure by the facility to offer all services (Campbell et al 2011).  
 
4.2.5 Theme 5:  Factors related to medication 
 
The fifth theme that was identified entails factors that are related to medication.  
Continuous drug supply of ARVs and pill administration were the two categories 
identified in theme 5. These will be discussed in detail as they are further sub 
categorised. 
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4.2.5.1 Uninterrupted supply of ARVs  
 
The hospital has managed to maintain a regular supply of ARVs for the patients. The 
patients are also supplied with extra three day supply of ARVs at each clinic visit to 
enable them to maintain high adherence levels as they never run out of supply of ARVs. 
The extra three day supply of ARVs enable them to cater for unforeseen emergencies 
that may occur before the patient comes back for the monthly refill as indicated from 
responses below:  
 
“This hospital has never run short of ARVs, every time when I come I 
always get my supply of ARVs except for Cotrimoxazole which we are 
asked to buy”. Female, 37-years-old. 
 
“I missed my appointment last month after I travelled to my rural home 
when my wife urgently told me that our daughter was sick. However I 
managed to come back two days after the appointment date but I did not 
miss any dose since I had extra doses”. Male, 47-years-old. 
 
Discussion 
 
A study done in Zambian rural areas revealed that non adherence was strongly 
associated with stock outs of ARVs, and  some patients were pressured to share ARVs 
with a family member or a friend until the other person secures his/her supply (Nozaki et 
al 2011:6). This was also supported by Posse et al (2008:95) that interruption of supply 
of ART due to financial constraints contributed to ART non adherence.  
 
4.2.5.2  Reduction in number of pills 
 
ARVs are taken on a daily basis and are a lifelong treatment that needs commitment 
from the individual. Taking too many pills on a daily basis was identified as a factor that 
may contribute to non-adherence as reported by participants: 
 
“The pills too many, can there be an injection to replace pills. I suggest that 
instead of taking tablets every day, they give us a monthly injection”. 
Female, 34-years-old. 
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“The pills are too many, find a cure taking ARVs for life is not easy, can they 
introduce one fixed dose tablet”. Male, 28-years-old. 
 
Discussion 
 
Pill burden was mentioned as one of the factors that may contribute to low adherence 
levels hence participants preferred a monthly injection or a fixed dose tablet. The 
findings of this study are consistent with those of Marukutira (2012:63) that pill burden 
and dosing times affected adherence levels. 
 
4.3 MOST PERCEIVED PROBLEMS AND POSSIBLE SOLUTIONS 
 
When participants were asked about the most perceived problem and possible solutions 
they had different views on possible solutions to improve ART adherence. The most 
perceived problem indicated by most of the participants was lack of food. Other 
problems identified were too frequent review dates, pill burden, failure to adhere to 
scheduled times, domestic violence and stigma interfering with adherence. Possible 
solutions suggested by participants were giving patients three months’ supply of ARVs 
at each visit, assisting patients with food, find a tablet or an injection that can be taken 
once a month, protection from domestic violence and stigma whilst one is on treatment, 
not to be transferred unconditionally to other health centres and conduct health 
education sessions on ART adherence to churches.  
 
4.4 CONCLUSION 
 
Findings from the study were discussed in this chapter. Five main themes emerged 
from the responses from participants and these were mainly related to patients’ 
knowledge levels, motivation to live, adherence support networks, service delivery and 
drug regimen factors. Discussions compared findings from this study with previous 
studies. Generally it was noted that many factors pertaining to service delivery that 
contributed to poor adherence revealed in most researches were not a problem at 
Beatrice Road Infectious Disease Hospital as some of them had been addressed. 
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CHAPTER 5 
 
SUMMARY OF RESEARCH FINDINGS, RECOMMENDATIONS, 
LIMITATIONS AND CONCLUSION 
 
 
5.1 INTRODUCTION 
 
This chapter presents a summary and interpretation of the research findings, 
recommendations, limitations of the study and conclusion. The study explored various 
factors that influenced adherence to ART among adult HIV positive patients attending 
antiretroviral therapy clinic at BRIDH. Findings from the study will be used to improve 
the ART programme thereby ensuring that patients on ART will fully enjoy the benefits 
of ART if they maintain high levels of adherence. 
 
5.2 RESEARCH DESIGN AND METHOD 
 
A qualitative study, with a descriptive phenomenological approach was used as it 
allowed participants to describe their experiences of the things they experienced in 
taking ART. Homogenous purposeful sampling method was used to identify suitable 
respondents basing on the inclusion criteria. Ethical considerations were respected and 
the researcher conducted face to face interviews with participants who volunteered to 
participate. The researcher also took notes and audio taped the conversations after 
obtaining consent from the participants. Twenty participants aged between 28 years and 
58 years, who had been on ART for a period of six months to nine years were 
interviewed.  
 
Data was analysed using the thematic analysis method described in Polit and Beck 
(2012:562).  
 
5.3 SUMMARY AND INTERPRETATION OF THE RESEARCH FINDINGS 
 
Study findings identified factors that influenced adherence to ART at BRIDH. Five 
themes emerged and these were mainly related to patients’ knowledge levels on HIV 
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and AIDS and ART, motivation to live, adherence support, service delivery and factors 
related to medication. 
 
5.3.1 Patients knowledge levels 
 
Participants were quiet knowledgeable about HIV basics and the role of ART, therefore 
the knowledge they had enabled them to maintain high levels of adherence. If a patient 
has full knowledge about disease condition and also well informed about how the drugs 
works they are likely to adhere better than those who are not informed. Those who had 
knowledge about the possible side-effects that can occur when one is taking ART 
maintained their adherence as they did not discontinue treatment when the side-effects 
occurred. Counselling played an important role in dissemination of information towards 
ART adherence. However, sometimes knowledge does not translate into action as 
evidenced by some patients who temporarily discontinued treatment after being ill 
advised by religious people. 
 
5.3.2 Motivation to live 
 
This theme identified factors that enabled patients to maintain high levels of adherence 
to ART. Participants who had enjoyed the benefits of ART were quite motivated to 
maintain high adherence levels by ensuring that they kept appointment dates and 
adhered to scheduled treatment times. Furthermore some even designed innovations 
that would make them to adhere such as making own treatment plan, adjusting social 
life to fit into ARV treatment, making use of meal times as reminders, use of cell phone 
alarms and carrying extra pills with them always. 
 
5.3.3 Adherence support 
 
Adherence support was the third theme identified that facilitated adherence to ART. 
Patients who were fully supported physically, psychologically, socially, emotionally and 
spiritually maintained high adherence levels. Social support networks which entail 
family, neighbours, relatives and peer support groups played a vital role in encouraging 
patients to adhere to their antiretroviral treatment. Support with food, health-related 
costs which entail availing ARVs free or making cost affordable and supporting PLHIV 
with income generating projects were some of the adherence facilitators identified.  
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Patients who were self-employed adhered better than those formally employed as they 
had no hustles in trying to obtain permission from their employers. 
 
However, the study revealed that participants, who were depressed, stressed, isolated, 
and had not disclosed their HIV positive status failed to adhere to their treatment as 
they were not getting the necessary support to adhere to ARV treatment. Some patients 
were not comfortable with decentralisation of the ART clinic as this would indirectly 
reveal their HIV positive status to their neighbours. 
 
5.3.4 Good service delivery 
 
Good services offered by health workers played an important role in ART adherence. 
Responses from participants indicated that they related well with the hospital staff, they 
were served within a reasonable time frame, the ART clinic was easily accessible and 
the comprehensive care services at the hospital enabled them to get all the services 
required when one is on ARV treatment. 
 
5.3.5 Factors related to medication 
 
There were no drug stock out experienced at the ART clinic therefore the continuous 
supply coupled with dispensing extra three day supply of ARVs to patients during every 
clinic visit to cater for unforeseen emergencies prevented interrupted supply of ARVs to 
patients hence promoted their adherence to ART treatment. 
 
5.4 RECOMMENDATIONS 
 
Recommendations were based on the challenges expressed by participants in making 
them adhere to the long life antiretroviral therapy. 
 
5.4.1 Recommendations to Harare City Health Department management 
 
5.4.1.1 Availability of food 
 
Most participants indicated that securing enough food was a challenge therefore 
needed to be assisted with food. To curb this problem there is need to source for more 
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donors that can assist with food to patients on ART who are unable to secure food for 
themselves irrespective of their nutritional status. It is also recommended that 
assistance with income for self-projects will help PLHWA to generate income that would 
enable them to cater for costs such as transport and other health costs. 
 
5.4.1.2 Self stigma 
 
Self-stigma is still a challenge with some patients on ART. Whilst decentralisation of 
ART clinics was welcomed by some patients, as it solved the problem of accessibility to 
ART clinics, the concept was not welcomed by some patients. Therefore there is need 
to consult patients first and make them decide the local clinic of their preference instead 
of making irrational decisions of transferring them to the nearest health centre. 
 
5.4.1.3 Service delivery at periphery centres 
 
Most participants indicated that there was very good service delivery at the initiating 
centre (BRIDH), however poor service delivery was identified at the periphery (local) 
clinic where patients were referred for their monthly supply. In view of that there is need 
for Harare City Health Management to identify closely and try to address the challenges 
occurring at these ART clinics.  
 
5.4.2 Recommendations to Ministry of Health 
 
5.4.2.1 Pill burden 
 
Participants’ responses indicated that it was not easy for them to remember to swallow 
pills on a daily basis and to follow the prescribed schedules, therefore recommended to 
programme planners to come up with a monthly injection or find a cure for HIV. 
 
5.4.2.2 Verbal abuse/domestic violence 
 
Some participants indicated that verbal abuse and domestic violence impacted 
negatively on their adherence. Therefore there is need to enforce law that protect them 
from the verbal abuse from their relatives and spouses. 
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5.4.2.3 Target churches on adherence 
 
From participants responses it came out that some churches and pastors are reversing 
the achievements so far towards ART adherence. There is need to intensify health 
education on HIV and AIDS and stress on importance of ART adherence to church 
leaders. 
 
5.4.2.4 Stigma and discrimination at work 
 
Despite HIV work related policies that were introduced at workplaces it came out that 
patients on ART were still experiencing work related stigma and this affected their 
adherence to ARV treatment. Therefore there is need to ensure that the HIV policy is 
enforced and respected at every work institution. 
 
5.5 LIMITATIONS OF THE STUDY 
 
Selection bias may have occurred due to the nature of non-probability studies which 
uses the purposive sampling method to select study participants. 
 
Due to the nature of face to face interviews there may be likely to be bias as some 
participants would give social desirable responses. Recall bias could also occur as 
participants were asked to recall when they missed doses or missed appointments. 
 
Some participants were not comfortable with audio recording as they indicated that the 
devices make them nervous and this would negatively affect their responses.  
 
Private rooms were not always available therefore the researcher had to wait for a long 
period until the room was available and some patients were not able to wait as they 
were in a hurry to back to work or to home to do other household chores. 
 
5.6 FURTHER RESEARCH 
 
The study focussed only on patients who came for their monthly review leaving out 
those who had discontinued treatment. Therefore there is need to follow up lost to follow 
up and conduct a research on why these patients decided to stop the treatment.  
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The study was also done in an urban setting with fewer challenges therefore there is 
need to conduct similar studies in rural areas especially the underserved communities. 
 
5.7 CONCLUSION OF THE STUDY 
 
This study explored factors contributing to ART adherence among adult patients 
attending antiretroviral therapy clinic at Beatrice Road Infectious Disease Hospital. 
Factors that influence adherence to ART identified in this study were grouped into five 
common themes and these were knowledge on HIV and AIDS and ART, motivation to 
live, adherence support networks, good service delivery and factors related to 
medication. 
 
A quote from Osterburg and Blaschke (2005:487) says “Drugs do not work to patients 
who do not take them” hence need to ensure strict adherence to the prescribed 
treatment. 
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Annex 2: Letter to City of Harare requesting for permission to conduct study 
 
1451 Silcox Avenue 
Houghton Park 
Harare 
Zimbabwe 
Contact: nkomo.gloria63@gmail.com 
Phone: +263772867771 
25 June 2013  
Attention: The Director of Health Services 
Harare Municipality 
Rowan Martin Building 
 
Dear Sir, 
Re: Permission to conduct research interviews at Beatrice Road Infectious 
Disease Hospital (BRIDH)  
 
My name is Gloria Nkomo, a Master in Public Health student from University of South 
Africa. I am kindly asking for permission to conduct an in depth study to explore factors 
that influence adherence to antiretroviral therapy among HIV and AIDS adult patients 
attending ART clinic at BRIDH. I would like to, with your permission, go to the centre to 
interview clients on ART. 
Voluntary informed verbal and written consent for participation will be obtained and 
participants will be asked to sign individual consent forms. Interviews will be conducted 
in a private room at the hospital where no one else can hear the conversation or at any 
convenient place agreed upon with the participant. Participants will be also assured of 
confidentiality of information and informed of the right to withdraw at any time and 
assured that non participation would not affect their treatment. Permission will be also 
sought to tape record the interviews and to take notes and assurance given that the 
information will be used for study purposes only. Fictitious names will be used and 
participants will be asked not to mention people’s names during the discussions. The 
  
2 
tapes and notes will be kept under lock and key. No identifying information will be 
collected and if negative comments regarding the institution will be made I will share 
that as well before publishing findings of the study.  
It is anticipated that findings from this study will assist patients on ART and communities 
to adopt behaviours that promote adherence and also ART programme planners would 
adopt policies that promote adherence to ART. 
Proposed dates for conducting the study are dates between 1st July 2013 and 14 
August 2013. 
I would be very glad to share the collated results in the form of a final report with you.  
 
Ethical clearance was provided by University of South Africa (UNISA). Should you have 
any queries please do not hesitate to contact my supervisor Ms A. Mosalo on 
+27124296447 or email, mosala@unisa.ac.za.  
 
Yours Faithfully, 
Gloria Nkomo (UNISA student number- 47188553). 
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Annex 5: Semi-Structured Interview Guide - English 
Semi-structured Interview Guide for in-depth interviews with patients on ART 
Procedure: 
Patients will be recruited when they come to the clinic to pick up their monthly 
medications. Purposive sampling (patients on ART) will be done with the assistance of 
one of the nurse counsellors, as there is an established relationship of trust with 
patients receiving treatment at this hospital. The participants who meet the selection 
criteria (18 years and above ART for more than 6 months) will be informed verbally 
about the study by the counsellor on the day they will be attending the clinic and a 
choice given to the participants to meet the researcher or to decline. The researcher will 
explain to the participants’ details of the study, then will hand over letters explaining the 
study and patient consent forms requesting permission to conduct the interviews with 
them as well as permission to audiotape the interviews. Once the letters of consent are 
returned, appropriate arrangements will be made for interviews to be conducted. 
A) Basic Information 
Name of interviewer: _________________________________________________ 
Interview number:__________Age of participant_______________Sex_________ 
Name of Health facility______________________________________________ 
Date:___________________________________________________________ 
 
B) Questions exploring adherence and non-adherence to antiretroviral treatment: 
Knowledge about HIV and Aids-Can you tell me what you know about HIV/AIDS? 
(Patient answers freely what he/she knows, possible responses mode of spread, 
prevention and that there is no cure). 
Knowledge about ARVs- Can you explain what you understand about ARVs? (Patient 
says freely what he/she knows, possible answers: not a cure, improves quality of life, 
prolongs life, lifelong treatment, knowledge about side-effects). 
Duration on ART- How long have you been on ART? 
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Perceived benefits about ARVs-How have ARVs changed your health status? 
 Missing appointments- Have you ever missed an appointment at your ART clinic over 
the past 3 months or any other time? (If yes, probe reasons) 
Missing doses: Have you ever missed a dose over the past three days? (If no, ask 
about the last seven days, if no again ask about the last month) What motivates you to 
continue taking your ARVs so consistently? Would you like to tell me the things that 
help you to remember taking your ARVs regularly and on time? 
(Non-adherer) Have you ever missed a dose in the last 3, 7, 30 days, what are the 
things that contributed to missing your dose?  
Adherence counselling- What are your views about adherence counselling? 
High risk behaviour- Would you like to tell me how alcohol abuse and drug abuse 
affect taking medicines as prescribed? 
Pill burden and side-effects- What are the main challenges you face in relation to pills, 
side-effects and food. Have you had your treatment changed at any moment since you 
were commenced on ARVs?  
Cost- What costs do you incur as a result of your taking ARVs? (Probe on travel 
expenses, clinic costs, payment for ARV medications if any). 
Distance to health facility- How do you think that distance to health facility affects 
adherence? 
Stigma- Have you ever had any experience of being treated differently because of your 
HIV status (In your family, work, church or community)? 
Disclosure and treatment support- Have you ever disclosed your status to anyone? If 
so, how what form of contribution? 
Cultural factors-From your own experience what are some of the cultural factors that 
could prevent someone from taking ARVs? 
Service delivery- What are your observations about service delivery at this hospital, 
that is, how do you relate with hospital staff during your review visits? (Probe: 
interpersonal relationship, privacy, confidentiality, respect, being listened to, time spent 
with patients, waiting time)  
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What suggestions do you have to improve service delivery at this hospital, if any? 
Perceived problems and possible solutions 
What do you perceive as the biggest problem regarding taking ARV treatment? 
What do you think could be done to improve this? 
Have you any questions for me? 
Thank you for your time and cooperation. 
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Annex 6: Semi-structured Interview Guide - Shona 
 
Semi-structured Interview Guide for indepth interviews with patients on ART 
Zita retsvagurudzo 
Tsvagurudzo yezvinokonzera kutevera kunwiwa kwemishonga zvakanaka pavarwere 
veHIV/AIDS vechikuru vanorapwa paBeatrice Road Infectious Disease 
Hospital,Harare,Zimbabwe. 
Gwara(Procedure): 
Varwere vachasarudzwa apo pavanenge vachiuya kuzotora mishonga yavo pamwedzi 
mumwe namumwe.Sarudzo yevarwere vari paART ichaitwa nerubatsiro kubva 
kunaMukoti sezvo vane hukama nevarwere varikurapwa pachipatara.Vachasarudzwa 
mutsvagurudzo iyi(vane makore gumi nemasere uye vave nemwedzi mitanhatu kana 
kupfuura vachirapwa pachipatara)vachaziviswa nezvetsvagurudzo iyi naMukoti nezuva 
ravachauya kuchipatara huye isarudzo yavo kuzvipira kuita tsagurudzo iyi pamwe chete 
nemutsvagurudzi kana kuramba.Mutsvagurudzi achatsanangura zvizere pamusoro 
petsvagurudzo,uye kupa tsamba dzinotsanangura tsvagurudzo pamwe chete netsamba 
inokumbira mvumo yekubvunza mibvunzo uye kutapa manzwi muhurukuro iyi.Kana izvi 
zvichinge zvaitwa uye mapepa emvumo adzoswa kune mutsvagurudzi zvino hurukuro 
ingachiitwa hayo. 
A) Basic Information 
Zita remutsvagurudzi:_______________________________________________ 
Interview number:__________Makore earikubvunzwa______Sex_________ 
Zita rechipatara______________________________________________ 
Zuva :___________________________________________________________ 
 B) Questions exploring adherence and non-adherence to antiretroviral treatment: 
Ruzivo pamusoro peHIV/AIDS-Mungandiudze here zvamunonzwisisa pamusoro 
peHIV/AIDS?(Bvumira murwere kusununguka kutaura zvaanoziva,bvunzurudza 
nezvekuparadzirwa,kudzivirirwa huye kurapwa kwacho. 
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Knowledge about ARVs-Mungandiudze here zvamunoziva pamusoro 
pemaARVs(Bvumira murwere kutsanangura kuti anorapa kana kuti haarapi 
chirwere,kumamwa zveupenyu hwese,uye nezvekurwadzisa muviri(side-effects) 
Duration on ART:Mave nenguva yakareba sei muri paART? 
Perceived benefits about ARVs-Mapiritsi aya(ARVs) arikushandura sei hutano 
hwenyu? 
Missing appointments:Pamwedzi mitatu yapfuura makambokundikana kuuya here 
pamakange manzi muuyekundoonekwa kuchipatara?Kana murwere akambodarikira 
bvunza chikonzero uye zvizere pamusoro pekukundikana kuuya ( reason for mising 
appointments). 
Missing doses:(Asina kumbodarikira Pamazuva matatu apfuura makambodarikira here 
kana kunonoka kunwa mapiritsi nenguva yakatarwa? Ko pazuva manomwe apfuura, 
kana pane mwedzi wapfuura? Chii chinokusundai kunwa mishonga yenyu 
sezvamakataurirwa kuchipatara.Zvii zvinokurangaridzai kunwa mishonga yenyu nguva 
dzose?(Mubatsiri,chiringa zuva,nhare mbozha kana mumwe wemumhuri menyu kana 
hama yenyu.) 
(Murwere akambodarikira)-Pamunombokanganwa kunwa mushonga chii chinenge 
chamboitika?Rubatsiro rupi rwamungade kukutondedzai kunwa mishonga zvakanaka? 
Adherence Counselling: Munemaonero api parubatsiro rwunopiwa kuti munhu 
anatsonwa mishonga yake? 
High risk behaviour:Munganditsanangurirewo here kuti zvinodhaka zvingavhiringa sei 
kunwa mishonga sekutaurirwa kwaakaitwa nachiremba? 
Pill burden and side-effects:Idambudziko ripi ramunosangana naro 
pamishonga,kurwadza miviri uye chikafu.Mishonga yenyu yakambochinjwa here kubva 
zvamakatanga kurapwa?Kana mhinduro yenyu iri hongu nemhaka yei?(Kuramba 
kushanda uye kurwadza muviri) 
Cost:Mutengo upi wamunosangana nawo nenyaya yekunwa mishonga(ARVs).Mari 
yekufambisa,Mari yekunyoresa,mari yekutenga mishonga uye kurasikirwa nemukana 
wekuita mari nekuuya kuchipatara. 
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Distance to health facility:Munoona sei nyaya yekuti mufambo(distance)wokuuya 
kuchipatara unokanganisa kunatsonwa mishonga yenyu? 
Disclosure and treatment support:Makambotaurirawo here chero mhunhu 
nezveurwerehwenyu?Ndiani?Pane rubatsiro rwamakambowana here kubva 
kumhuri,nharaunda kana shamwari kubva pamatanga mishonga. 
Cultural Factors:Kubva pamaonero enyu itsika dzipi uye maonero api angadzivisa 
murwere kutora mushonga wake(ARVs) sezvaanotarisirwa. 
Service Delivery:Ndezvipi zvimwe zvezvamunoona pakubatsirwa kunoitwa varwere 
pano pachipatara sekuti pamunouya kuzowonekwa,(Tsvagurudza mabatirwo avanoita 
nevasevenzi vepachipatara,kusafumurwa,rukudzo,kutererwa,nguva inotorwa 
nemurwere,nguva yekumirira,rumwe rubatsiro runopiwa pachipatara. 
Perceived problems and solutions:Nderipi ramungati idambudziko pakutora 
mushonga?Zvii zvingaitwa mukupedza dambudziko irori? 
Mungaita mubvunzo here? 
Maita basa nekuterera uye nenguva yenyu. 
 
 
 
 
 
  
1 
Annex 7: Participant Informed Consent - English 
INFORMED CONSENT FORM FOR CLIENTS ON ART 
PROJECT TITLE 
A study to explore factors that influence adherence to antiretroviral therapy among HIV 
and AIDS adult patients attending ART clinic at Beatrice Road Infectious Disease 
Hospital, Harare, Zimbabwe. 
Principal Investigator: Gloria Nkomo  
Contact: Phone number: +263867771, email: nkomo.gloria63@gmail.com  
 
Supervisor: Ms A Mosalo. mosala@unisa.ac.za or +27124296447 
 
What you should know about this research study: 
• We give you this consent so that you may read about the purpose, risks, 
and benefits of this research study. 
 
• Routine care is based upon the best known treatment and is provided 
with the main goal of helping the individual patient.  The main goal of 
research studies is to gain knowledge that may help future patients. 
 
• We cannot promise that this research will benefit you.  
 
• You have the right to refuse to take part, or agree to take part now and 
change your mind later. 
 
• Whatever you decide, it will not affect your regular care. 
 
• Please review this consent form carefully.  Ask any questions before you 
make a decision. 
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• Your participation is voluntary. 
 
PURPOSE 
 You are being asked to participate in a research study of factors contributing to 
adherence of ART among HIV adult attending antiretroviral clinic.The purpose of the 
study is to explore factors contributing to adherence of antiretroviral therapy.You were 
selected as a possible participant in this study because you have experiences of taking 
ARVs and you are one of 15 participants that have been selected. 
 
PROCEDURES AND DURATION 
If you decide to participate, the researcher will conduct a face to face interview with you 
relating to your experiences about factors that contribute to adherence to ART. The 
interviews will take approximately one hour. 
RISKS AND DISCOMFORTS 
There are no risks or discomforts known but probably you may experience emotional 
feelings of sadness and if it occurs you will be referred to your counsellor for 
counselling. 
  
CONFIDENTIALITY 
If you indicate your willingness to participate in this study by signing this document, the 
researcher will conduct interviews in a private room at the hospital allocated to the 
researcher. The researcher will take notes and audio-tape the interviews with your 
permission and the information will be kept at a secure place. Also there will be no 
mention of other people’s names during the interview. Any information that is obtained 
in connection with this study that can be identified with you will remain confidential and 
will be disclosed only with your permission. Only the researcher, the university and the 
research ethics committee will have access to this information. Under some 
circumstances, the MRCZ may need to review patient records for compliance audits.  
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The researcher will give feedback on the findings of the study to those who participated 
in the study and the director of Harare City Health Department. 
 
ADDITIONAL COSTS 
No additional costs will be incurred by your participation.  
 
VOLUNTARY PARTICIPATION 
Participation in this study is voluntary therefore you are free to choose either to 
participate or not to participate.  If you decide not to participate in this study, your 
decision will not affect your future relations with the Beatrice Road Infectious Disease 
hospital, its personnel, and associated hospitals. If you decide to participate, you are 
free to withdraw your consent and to discontinue participation at any time without 
penalty. 
 
OFFER TO ANSWER QUESTIONS 
 Before you sign this form, please ask any questions on any aspect of this study 
that is unclear to you.  You may take as much time as necessary to think it over. 
 
AUTHORIZATION 
 You are making a decision whether to participate or not to participate in this 
study.  Your signature indicates that you have read and understood the information 
provided above, have had all your questions answered, and have decided to participate. 
 
Research Title: A study to explore factors that influence adherence to antiretroviral 
therapy among HIV and AIDS adult patients attending opportunistic infection clinic at 
Beatrice Road Infectious Disease Hospital, Harare, Zimbabwe 
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Name of Research Participant (please print)  Date 
 
 _______________________________  _____________________________ 
Signature of Witness Signature of Staff Obtaining Consent 
(Optional)  
 
 YOU WILL BE GIVEN A COPY OF THIS CONSENT FORM TO KEEP. 
 
If you have any questions concerning this study or consent form beyond those 
answered by the investigator, including questions about the research, your rights as a 
research participant or research-related injuries; or if you feel that you have been 
treated unfairly and would like to talk to someone other than a member of the research 
team, please feel free to contact the Medical Research Council of Zimbabwe on 
telephone 791792 or 791193. 
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Annex 8: Consent to Audio recordings 
Audio Recording  
The interviews will be tape (audio) recorded with your permission. The tapes will be 
used  
(played)  by the researcher after the interview to ensure that all the participant 
information is  
captured.  Participants may have the option of hearing the tapes prior to use by the 
researcher.  
Upon completion of the study the tapes will be destroyed. 
 Statement of Consent to be  Audiotaped. 
I understand that audio recordings will be taken during the study. (Mark either “Yes” or 
“No”) 
 
• I agree to being audio recorded   Yes  
 
          No  
    
Name of Research Participant (please print)  Date 
 
     
Signature of Participant  Time  
     
____________________                      ________________ _____________  
Name of Staff Obtaining Consent (please print) Signature  Date 
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Annex 9: Participants Informed Consent - Shona 
Gwaro rekuzivisa nekutsvaga mvumo pavanhu vari pa ART (Informed consent 
form for clients on ART)  
Zita retsvagurudzo 
Tsvagurudzo yezvinokonzera kutevedzera kunwiwa kwemishonga (ARVs) zvakanaka 
pavarwere veHIV ne AIDS vechikuru vanorapwa paBeatrice Road Infectious Disease 
Hospital, Harare,  Zimbabwe. 
Zita remutsvagurudzi : Gloria Nkomo  
Phone number: +263772867771, email: nkomo.gloria63@gmail.com  
Vanotungamira Tsvagurudzo : Ms A  Mosalo. mosala@unisa.ac.za or +27124296447 
Zvamunofanira kuziva pamusoro petsvagurudzo 
• Ndichakupai gwaro iri kuti muzive chinangwa, njodzi pamwe chete 
nezvakanakira tsvagurudzo iyi. 
• Kunatso rapwa kwenyu kunoenderana nokunatsoziva mushonga chinangwa 
chokubatsira murwere. Chinangwa chikuru ndechekuwana ruzivo ruchazobatsira 
varwere vanotevera. 
• Handingakuvimbisei rubatsiro kubva mutsvagurudzo, asi sezvingangoitwa 
mukurapwa,tsvagurudzo iyi inogona kukonzeresa zvimwe zvinhu 
zvatisingatarisiri zvingave zvihombe kana zvidiki. 
• Munekodzero yekuramba kana kubvuma kupindura mibvunzo yetsvagiridzo iyoyi, 
uye munogona kushandura  mafungiro enyu kunyange ongororo ichinge 
yavapakati. 
• Chero  sarudzo yamunenge maita haikukanganisii kurapwa kwenyu. 
• Natsai henyu kuverenga gwaro rino. Bvunzai mibvunzo musati maita sarudzo 
yenyu.  
• Kupinda kwenyu mutsvagurudzo iyi hakumanikidzwe munhu. 
Chinangwa chetsvagurudzo (Purpose) 
Murikukumbirwa kuti mupinde mutsvagurudzo ine chinangwa chokuda kunzwisisa 
zvikonzero zvinoita kuti varwere veHIV vakwanise kunwa mishonga (ma ARVs) yavo 
nemazvo (adherence). Zvichabuda muongororo iyi zvichabatsira kuti vanhu vari pama 
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ARV vakwanise kunwa  mishonga yavo zvakanaka. Makasarudzwa kuti mupinde 
musarudzo iyi nekuda kwekuti munonyatsonzwisisa zvokunwa maARVs uye muri 
mumwe wevanhu gumi nevashanu vachapinda mutsvagurudzo iyi. 
Zvichaitwa patsvagurudzo (Procedure and Duration) 
Kana mabvuma kupinda mutsvagurudzo, mutsvagurudzi achakurukura nemi, 
achikubvunzai mibvunzo yakanagana nekunwa kwamuri kuita ma ARVs enyu, uye 
muchipawo pfungwa dzenyu maererano nekutevedzera kunwiwa kwemushonga. 
Hurukuro iyi ingangotora nguva inoita awa rimwe chete(1 hour). 
Njodzi ne kusagadzikana (Risk and Discomfort) 
Hapana njodzi kana kusagadzikana kungangowanikwa nekupinda kwenyu 
mutsvagurudzo asi mungave  munogona kusurukirwa kana madzamisa pfungwa 
dzenyu zvakanyaya. Kana izvi zvichinge zvaitika munotaura nacounsellor wenyu. 
Tsindidzo (Confidentiality) 
Kana mazvipira kupinda musarudzo iyi uye kana manyora chibvumirano pabepa iri 
(consent form) mucha bvunzwa muri muimba isina ani zvake anganzwe kana kuona. 
Hurukuro yedu tichai tapa manzwi, uye mutsvagurudzi achange achinyora pasi minduro 
dzenyu mushure mekunge tawana mvumo yenyu. Zvinyora izvi nezvitapwa(video tapes) 
zvichachengetedzwa panzvimbo isingagone kuvhurwa nemunhu wese wese. 
Zvichabuda muhurukuro iyi zvichango zivikanwa neni, mudzidzisi wangu neve bato 
rinoongorora nezvetsvagurudzo, uye hatitaure mazita evamwe  muhurukuro yedu. 
Nedzimwewo nguva bazi reMRCZ rinogona kuda kuzoongorora kuti vaone kuti 
zvirikuitwa negwara chairo here.  Mutsvagurudzi achakuudzai zvinenge zvabuda 
mutsvagurudzo iyi uyezve achaudzawo mukuru weveutano ku Harare City Health 
Department. 
Mitengo inodiwa (Additional costs) 
Hakuna mutengo wamunosangana nawo pakupinda musarudzo ino. 
Kubvuma pasina kumanikidzwa (Voluntary Participation) 
Hamumanikidzwi kupinda mutsvagurudzo iyi, naizvozvo munogona kubvuma kana 
kuramba. Kana dai muchinge mabvuma makasununguka kubuda muhurukuro iyi chero 
nguva ipi zvayo kana muchinge musisade. Kana mukasarudza kubuda mutsvagurudzo  
  
4 
hamuna mhosva kana mutongo wamunopiwa uye hazvikanganisi kurapwa hwenyu  
kana kuchinja ukama hwenyu neve pa Beatrice Road Infectious Disease hospital, 
vashandi vayo kana zvimwe zvipatara zvakafanana. 
Kodzero yekubvunza mibvunzo (Offer to answer questions) 
Musati mabvuma nekunyora zita renyu (signature) pabepa rino, sunungukai kubvunza 
mibvunzo isina kujeka kwamuri. Sunungukai kuita izvi  nenguva yenyu yakafanira 
muchinyafunga nezvazvo. 
Mvumo (Authorisation) 
Murikuita sarudzo yokupinda mutsvagurudzo, runyoro rwenyu (signature) runotaridza 
kuti magutsikana nezvakanyorwa pamusoro , mibvunzo yenyu yose yapindurwa uye 
mabvuma kupinda mutsvagurudzo. 
Zita retsvagurudzo 
Tsvagurudzo yezvinokonzeresa kusatevera kunwiwa kwemishonga zvakanaka 
pavarwere veHIV/AIDS vechikuru vanorapwa paBeatrice Road Infectious Disease 
Hospital,Harare,Zimbabwe. 
 
    
Name of Research Participant (please print)  Zuva 
 _______________________________  ______________________ 
Signature yaanopupura (witness) Zita remushandi apamvumo 
MUCHAPIWA RIMWE GWARO RAKAITA KUNGE RINO KUTI MUCHENGETE. 
 
Kana munemibvunzo pamusoro petsvagurudzo iyi,ngwaro ramanyora mvumo, 
mubvunzo yetsvagurudzo, kodzero dzenyu, kana zvimwe zvingadai zvakukanganisai 
kana pamusina kubatwa zvakanaka kana zvakare muchida kutaura nemumwe asiri 
pakati pevatsvagurudzi sunungukai kuphona ku Medical Research Council of Zimbabwe 
pa nhamba dzinoti 791792 or 791193. 
  
 
Annex10: Consent to Audio-Recording - Shona version 
Kutapwa kwemanzwi (Audio Recordings) 
Hurukuro yose ichatapwa manzwi mushure mekunge tawana mvumo yenyu. 
Zvakatapwa zvicharidzwa kuti mutsvagurudzi anatsowana zvose zvakataurwa 
muhurukuro. Makasununguka kunzwa zvakatapwa zvisati zvashandiswa 
nemutsvagurudzi uye tsvagurudzo ichingopera zvose zvakatapwa zvichaparadzwa. 
Gwaro rekubvuma kutapwa manzwi (Statement of Consent to be Audiotaped). 
Ndanzwisisa kuti mazwi achatapwa muhurukuro yetsvagurudzo.(Bvumai kana 
kuramba). 
 
Ndobvuma kutapwa mazwi mutsvagurudzo 
  Hongu  
 
                   Kwete  
Name of Research Participant (please print)  Date 
     
Signature of Participant  Nguva  
 _______________________________ ___________________        
________________ 
  
     
______________________________ ___________________         
_____________  
Zita remutsvagurudzi apamvumo 
(please print) 
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Annex 11:  Medical Research Council of Zimbabwe Application Letter 
MEDICAL RESEARCH COUNCIL 
OF ZIMBABWE 
APPLICATION FOR REGISTRATION TO CONDUCT RESEARCH 
 
 
 
 
 
 
 
 
This form must be completed by all persons/teams intending to conduct 
health/medical research in Zimbabwe. Upon completion by the investigator(s) it 
should be submitted to the Institutional Review Board(IRB) of the institution in 
which/under which the research is to be conducted.  Upon completion of the 
relevant section by the IRB, the form should be submitted to the Secretary, 
Medical Research Council of Zimbabwe, P O Box CY 573 , Causeway, Harare.  A 
registration fee should accompany each application.  Cheques should be made 
payable to the Medical Research Council of Zimbabwe (MRCZ) 
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MEDICAL RESEARCH COUNCIL 
 OF ZIMBABWE 
For Office Use Only 
 
MRCZ/A/………..… 
 
FC EXP  XMPT  
 
 
MRCZ FORM    101 
Date received 
……………… 
 
APPLICATION TO CONDUCT HEALTH/MEDICAL RESEARCH 
 
This form must be completed by all persons/teams intending to conduct 
health/medical research in Zimbabwe. Upon completion by the investigator(s) it 
should be submitted to the Institutional Review Board (IRB) of the institution in 
which/under which the research is to be conducted.  Upon completion of the 
relevant section by the IRB, the form should be submitted to the Secretary, 
Medical Research Council of Zimbabwe, P O Box CY 573, Causeway, Harare.     
 
Protocol Version Number :………………. 
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Details of Research Team 
 
Name of Principal Investigator (P.I) Gloria Nkomo 
Nationality of P.I Zimbabwean 
Existing Qualifications Bachelor of Arts in Nursing 
Academic Title Public Health Nurse 
Institution & Dept. N/A 
Postal address 1451 Silcox Avenue, Houghton Park, 
Harare 
E-mail address Nkomo.gloria63@gmail.com 
Telephone No. +263772867771 
Is this research expected to lead to the 
award of a higher degree? (Yes/No) 
Yes 
University/Institution where registered University of South Africa (UNISA) 
 
Details of the Proposed Research 
 
Title of proposed research 
 
 
A study to explore factors that influence 
adherence to antiretroviral therapy among HIV 
and AIDS adult patients attending antiretroviral 
therapy  clinic at Beatrice Road Infectious 
Disease Hospital, Harare, Zimbabwe. 
Proposed starting date 01/07/2013 
Proposed ending date 14/08/2013 
Performance site(s) in Zimbabwe              Beatrice Road Infectious Disease Hospital  
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Performance sites (outside 
Zimbabwe) 
None 
Total number of study personnel 3 
Budget (state currency) US$2500 
Name and address of Funding 
agency: 
Self 
Status of funding : a)Submitted for funding       b)Pending     
c)Funded  
 
Population : Proposed inclusion criteria 
(Check all that applies) 
Males                                                :  
Females                                             :  
Adolescents (12 – 17 years)              :  
Children (Under 12 years of age)     :  
Pregnant women                               :  
Foetuses                                             :  
Elderly (over 65 years)                      :  
       Prisoners                                            :  
Cognitively impaired                         :  
Hospital inpatients                             :  
 
 
Type of study(check all that 
applies) 
 
Survey                               :  
Secondary data               :  
Program Project                :  
Clinical community trial  :  
Case control                      :  
Longitudinal study          :  
Record review                  :  
Course activity                 :  
Other (specify)                : 
Descriptive Phenomenological 
 
  
5 
Consent Process(Check all that applies) 
Written :           English :          Local Language :  
 
 
Proposed sample size             Approximately 15 Patients (Data will be collected 
until saturation occurs). 
 
Reading level of consent document : 
 Below Grade 3     Below Grade 6    Below Form 2     Below Form 4     
Above O level      Graduate level  
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Determination of Risk(Check all that applies) 
 
Does the research involve any of the following YES NO 
Human exposure to ionizing radiation   
Fetal tissue or abortus   
Investigational new drug   
Investigational new device   
Existing data available via public archives/sources   
Existing data not available via public archives   
Observation of public behaviour   
Is the information going to be recorded in such a way that participants 
can be identified 
  
Does the research deal with sensitive aspects of the participants 
behaviour, sexual behavior, alcohol use or illegal conduct such as drug 
use 
  
Could the information recorded about the individual if it became known 
outside of the research, place the participants at risk of criminal 
prosecution or civil liability 
  
Could the information recorded about the individual if it became known 
outside of the research, damage the participant’s financial standing, 
reputation and employability? 
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• Do you consider the proposed research 
A) greater than minimal risk    
B) minimal risk                           
C) no risk                                 
 
Minimal risk is a risk where the probability and magnitude of harm or discomfort 
anticipated in the proposed research are not greater in and of themselves than 
those ordinarily encountered in daily life or during the performance of routine 
physical, psychological examinations or tests.  For example the risk of drawing a 
small amount of blood from a healthy individual for research purposes is no 
greater than the risk of doing so as part of routine physical examinations. 
 
• Do any of the participating investigators and or their immediate families have an 
equity relationship with the sponsor of the project or the manufacturer or owner of 
the drug or device under investigation or serve as a consultant to any of the 
above?    YES       NO  
If yes, please submit a written statement of disclosure to the Chairperson of the 
MRCZ  
 
 
SIGNATURE ASSURANCE SHEET 
Principal Investigator's Assurance Statement: 
 I certify that the information given by me is correct to the best of my knowledge, I 
am familiar with and understand the Medical Research Council of Zimbabwe's 
policy concerning research involving human participants (CIOMS Guidelines or 
Helsinki Declaration) and I agree: 
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 (Please check all that applies) 
 
 1. to accept responsibility for the scientific and ethical conduct of this research 
study; 
 
 2. to obtain prior approval from the relevant IRB as well as the MRCZ before 
amending or altering the research protocol or implementing changes in the 
approved consent form; 
 
 3. to immediately report to the relevant IRB and the MRCZ any serious adverse 
reactions and/or unanticipated effects on participants which may occur as a 
result of this study; 
4. to complete and submit the Continuing annual Review Form annually (when 
due) as well as the Final/Study termination form at the end of the proposed 
study. 
5. to submit the final study report to the MRCZ using standard form (MRCZ 
Termination Form 105). 
6. to pay one percent levy to the MRCZ upon approval of my protocol (for study 
monitoring and  general research participants protection requirements). 
 
 Signature G. Nkomo  Date 05/07/2013 
      
 Print name GLORIA NKOMO    
      
 Signature of Co-investigator   Date  
 Print Name     
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